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Abstract 
The koala occupies a significant position in Australian culture and ecology. It is the 
last surviving member of the family Phascolarctidae. Despite the iconic position 
enjoyed by this marsupial, its survival is threatened by a number of factors. There are 
many reasons behind the increasing decline observed in koala populations with 
habitat destruction and debilitating Chlamydia infections being the major ones. 
Chlamydial infection in the koala results in increased morbidity, mortality and 
reduced reproductive capacity, thus posing a threat to the survival of this important 
marsupial. Chlamydia pecorum and Chlamydia pneumoniae have been identified as 
the two main aetiological agents responsible for chlamydial disease in the koala, with 
the former being more pathological and wide spread. Infections of the ocular, 
respiratory and urogenital tract have been reported. Unilateral or bilateral ocular 
infections manifest as keratoconjunctivitis leading to blindness in chronic cases. 
Rhinitis and pneumonia are associated with respiratory infections. Continual urine 
soiling due to incontinence results in a ‘wet bottom’ or ‘dirty tail’ appearance, which 
is a manifestation of cysts in the urinary bladder due to urinary tract chlamydial 
infection. Infections of the genital tract, which are inapparent externally, can cause 
severe inflammation and fibrosis, resulting in cystitis and infertility. Studies are 
underway to develop a vaccine against chlamydial infection in koalas, which is the 
major cause of infection, disease, infertility and subsequent mortality in this animal. 
To fully understand the effectiveness of this initiative, a better understanding of the 
natural immune response of the koala to chlamydial infection is required. This would 
facilitate a better understanding of the immune response elicited by koalas to 
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vaccination initiatives. Limited knowledge regarding koala immunology combined 
with the absence of koala specific immune assays, has restricted the work in this 
field. Moreover, an understanding of koala immunology would also help to better 
understand the unique marsupial immune system and the degree of its relatedness to 
the eutherian mammalian immune system. It is in this context that the study 
involving development of immunological assays becomes relevant. It is well 
established that cell mediated immunity (CMI) is the principal immune response 
generated by the host against chlamydial infection in other species. Hence, in an 
attempt to understand the cell mediated immune response of the koala to chlamydial 
infection, my current study aimed to (a) clone and sequence selected cytokines 
known to play a role in chlamydial disease pathogenesis (b) optimise and develop 
quantitative real time PCR (qrtPCR) based assays to measure the gene expression of 
these cytokines in the koala (c) apply these assays to quantitate cytokine expression 
in Peripheral Blood Mononuclear Cells (PBMCs) in koalas suffering from 
chlamydial disease/infection, to understand chlamydial disease pathogenesis.  
 
The primary aim of this study was to clone and sequence four key cytokines known 
through studies in humans and animal models to play a pivotal role in chlamydial 
disease pathology and protection against infection. Tumour Necrosis Factor alpha 
(TNFα), Interleukin 10 (IL10), Interferon gamma (IFNγ) and Interleukin 17A 
(IL17A) were the cytokines of interest chosen. TNFα is a pro-inflammatory cytokine, 
IL10 a principal anti-inflammatory Th2 cytokine, IFNγ a principal pro-inflammatory 
Th1 cytokine and IL17A a principal pro-inflammatory Th17 cytokine. The 
methodology for koala cytokine sequence identification was PCR amplification of 
the target region using primers based on alignment of consensus sequences from 
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other marsupial species such as brushtail possum, tammar wallaby, opossum and 
Tasmanian devil. The primers were designed along areas of high conservation to 
maximise the chance of koala sequence isolation. On successful amplification, the 
PCR product was cloned and sequenced.  The relatively conserved nature of TNFα, 
IL10 and IL17A sequences enabled the successful use of this methodology. 
However, the low level of sequence conservation for IFNγ and the limited 
availability of orthologous marsupial sequences, posed a challenge in the use of this 
methodology for koala IFNγ sequence isolation. This problem was overcome with 
the sequencing of the koala transcriptome by our group and subsequently the IFNγ 
mRNA sequence was available for qrtPCR assay design. 
 
For qrtPCR (quantitative real time Polymerase Chain Reaction) assays were designed 
using the SYBR Green dye based chemistry. The primers for these assays were 
designed to span an intron-exon junction to avoid co-amplification of genomic DNA. 
A housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), was 
also cloned and sequenced from the koala as part of this study to serve as a reference 
gene and to compensate for input sample amount variations. The cytokine gene 
expression was normalised to GAPDH by the 2−ΔΔCT method, where ΔΔCT = (Ct of 
target − Ct of GAPDH) at any time point − (Ct of target − Ct of GAPDH) at time 
zero hour.  
 
Initially, the time of optimal cytokine gene expression in the koala had to be 
established. For this (Peripheral Blood Mononuclear Cells) PBMCs isolated from 
koala blood samples were stimulated with the mitogen, ConA, and incubated at 37oC 
for different time periods (2hrs, 3hrs, 4hrs, 6hrs, 8hrs, 10hrs, 12hrs, 24hrs, 48hrs, 
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72hrs). It was noted that optimal cytokine expression occurred between 10 and 12 
hours. These assays were then applied to quantify systemic cytokine gene expression 
in koalas suffering from chlamydial disease, chlamydial infection without disease 
and in koalas with no evidence of chlamydial infection. Perhaps not surprisingly, 
considerable variation was observed amongst individual animals in the cytokine 
expression patterns in the cohorts of koalas that were studied. In the first cohort, both 
anti-inflammatory (IL10) and pro-inflammatory (TNFα and IFNγ) cytokines were 
elevated in animals with current disease.  However, a general trend of higher 
expression of pro-inflammatory cytokines, TNFα, IFNγ and IL17A, was observed in 
animals with signs of current chlamydial disease in the second cohort. Amongst the 
four cytokines analysed, a statistically significant enhanced expression of IL17A was 
observed in animals with current chlamydial disease. The pro-inflammatory 
cytokines investigated as part of this study are known to have a role in 
immunopathology during chlamydial disease based on evidence from other animal 
models. Hence, it can be inferred that they probably play a similar role in this 
marsupial host leading to the clinical disease manifestations. 
 
The qrtPCR cytokine assays developed as part of this study serve as important tools 
to understand the host-pathogen interaction in the koala. They can also be applied to 
investigate the efficacy of therapeutic and prophylactic interventions such antibiotic 
treatment and vaccination. This study has also established a solid foundation for 
continued work in the field of koala-Chlamydia immunology. However, further 
studies are required to extend our understanding of this host-pathogen interaction 
which would benefit disease management at the level of individual animals and aid 
in the long term survival of this Australian marsupial.  
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Chapter 1: Introduction 
1.1 A DISCUSSION OF THE SCIENTIFIC PROBLEM INVESTIGATED 
The koala (Phascolarctos cinereus) is an Australian arboreal marsupial and the last 
surviving member of the family Phascolarctidae. It enjoys a unique position in 
Australian culture and contributes to the country’s rich reputation for biodiversity. 
Moreover, it makes a significant contribution to the Australian tourism industry. A 
study conducted by ‘The Australia Institute’ in 1997 estimated that koala-based 
tourism contributes about $1.1 billion/year to the economy and around 9000 jobs 
(Hundloe and Hamilton, 1997). With the growth in tourism in Australia, it can be 
assumed that these figures would have increased over the decades. 
 
In spite of its unique position, it has been observed that koala populations in certain 
parts of Australia are experiencing a steady decline (Melzer et al., 2000; Gordon et 
al., 2005; McAlpine et al, 2006). Factors behind this decline include habitat 
destruction (Melzer et al., 2000), natural disasters (Lunney et al., 2007), dog attacks 
(Rhodes et al., 2006), motor vehicle accidents (Dique et al., 2003) and infectious 
diseases such as chlamydiosis (McColl et al., 1984; Brown et al., 1987) and koala 
retrovirus (Hanger et al., 2000). Even though habitat destruction is the most critical 
threat to koala populations, it is important to focus on diseases that affect this animal 
as this could have a significant impact on stabilising existing koala populations 
(Rhodes et al., 2011).  
 
Chlamydia is a major cause of infection in koalas with infection levels ranging from 
zero in certain island populations to 72-100% in certain free range koalas 
 2 Chapter 1: Introduction 
(Polkinghorne et al., 2013). C. pneumoniae and C. pecorum are associated with 
chlamydial disease in koalas, the latter being more prevalent and pathogenic (Girjes 
et al., 1988; Glassick et al., 1996). Chlamydia infection in koalas has been associated 
with rhinitis, cystitis, proliferative conjunctivitis and chronic, fibrotic disease of the 
urogenital tract leading to infertility and death (Polkinghorne et al., 2013). 
Chlamydial infection is a sexually transmitted disease. Dominant male koalas, 
infected with Chlamydia, transmit the disease sexually to mature females during 
sexual contact, as a urogenital tract infection. The aggressive mating behaviour of 
koalas might be the means of ocular transmission of the organism (Jackson et al., 
1999). It may also be spread from the mother to joey during paap feeding (Blanshard 
and Bodley, 2008). 
 
The pathogenesis of Chlamydia is attributed to the complex interaction between the 
pathogen and the host during its replication and dispersion within the host. 
Chlamydia is an obligate intracellular bacterium which has a biphasic developmental 
cycle characterised by an extracellular metabolically inert elementary body (EB) and 
an intracellular metabolically active reticulate body (RB) (Moulder et al., 1991). 
Chronic disease associated with persistence, inflammation and tissue damage is 
characteristic of chlamydial infection. Inflammatory effects of the cytokines 
involved in immunological response against the organism have been linked to the 
tissue damage observed in chronic chlamydial disease (Rasmussen et al., 1997; 
Mascellino et al., 2011).   
 
Cell mediated immunity (CMI) is well established as the major immune response 
generated by the host against chlamydial infection (Rank et al., 1985; Ramsey et al., 
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1988; Su et al., 1997). This study investigates the role of principal cytokines secreted 
by T cell subsets, Th1, Th2 and Th17, in the koala chlamydial disease pathogenesis. 
The classical Th1 and Th2 cells (Mosman et al., 1989) along with the newly 
described Th17 T helper cell population (Infante-Duarte et al., 2000) have been 
implicated in chlamydial disease. Cytokines secreted by Th1 subpopulation of major 
histocompatability complex (MHC) class II restricted CD4+ cells play a central role 
in resolution of chlamydial infection, with MHC class I restricted CD8+ cytotoxic T 
lymphocytes playing a secondary role (Yang and Brunham, 1998; Igietseme et al., 
2009; Farris et al., 2010). Of the various cytokines secreted in response to 
chlamydial infection, IFNγ plays a critical role. It inhibits chlamydial infection by 
various pro-inflammatory mechanisms and by depriving the organism of energy and 
nutrition, thereby limiting its growth (Shemer and Sarov, 1985; Rottenberg et al., 
2000; Rottenberg et al., 2002). However, studies show that IFNγ may not be able to 
completely resolve chlamydial infection (Ramsey et al., 2001) and may result in 
persistence. A decrease in chlamydial antigen levels results in diminished IFNγ 
levels, leading to reactivation of chlamydial replication and infection. This 
intermittent cycle of infection and inflammatory responses is responsible for the 
immunopathology associated with chlamydial infection. TNFα, an inflammatory 
cytokine, acts synergistically with IFNγ and has been associated with the 
development of pathology during chlamydial infection (Conway et al., 1997; Murthy 
et al., 2011) in both human and mouse models of infection. In a mouse model of 
chlamydial respiratory infection, absence of TNFα during the immune response is 
associated with increased dissemination of infection and mortality (Williams et al., 
1990; Njau et al., 2009). So similar to IFNγ, expression of TNFα in a host is 
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associated with both host defence and pathological sequelae associated with 
chlamydial infection 
 
IL10, a principal Th2 cytokine, plays a critical role in chronic chlamydial infection. 
It is an anti-inflammatory cytokine the principal function of which appears to be to 
limit and ultimately terminate inflammatory responses (Moore et. al., 2001). 
Evidence from animal studies show severe inflammatory response in the absence of 
IL10 along with the presence of high levels of pro-inflammatory cytokines (Pentilla 
et al., 2008).  Recently, it has been postulated that immune response to Chlamydiae 
may be maintained by Th2 immune responses that control bacterial growth but 
minimize immunopathological damage to the host (Miguel and Cherpes, 2012). 
However, its role remains to be investigated in the koala. 
 
 Recently, a growing body of work has been dedicated to investigate the role of 
IL17A, a pro-inflammatory Th17 cytokine in chlamydial pathogenesis. An early 
IL17A production in the initial stages of chlamydial infection is linked to clearance 
of infection in the mouse model (Zhang et al., 2009; Scurlock et al., 2011). However, 
it is also seen to play a role in the development of immunopathology in the murine 
model following respiratory and genital tract chlamydial infections (Andrew et al., 
2013; O’Meara et al., 2013a; O’Meara et al., 2013b). Even though enhanced 
expression of IL17 coincided with protection from infection, an exacerbation of 
pathology in the experimental animal was also observed in these studies. This was 
attributed to the recruitment of inflammatory cells such as macrophages and 
neutrophils. Hence, it would be interesting to investigate the role played by this 
cytokine in koala chlamydial pathology.  
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Despite the severity and high prevalence of chlamydial infection in koalas, very little 
is known about the immune response to the organism. In fact, very little is known 
about the immune system of the koala. Early studies have suggested the koala to be 
an ‘immunologically lazy’ animal as it demonstrated a delayed humoral immune 
response compared to eutherian mammals (Wilkinson et al., 1992). However, these 
claims have not been supported by data from recent studies involving chlamydial 
vaccine trials in the koala (Carey et al., 2010; Kollipara et al., 2012; Kollipara et al., 
2013). All the studies were able to demonstrate significant humoral and CMI 
response to chlamydial antigens. However, the studies were unable to comment on 
the cytokine profile of the CMI response observed as there were no assays currently 
available to measure this response. As explained before, cytokines are central to the 
immune response by a host against Chlamydia. In order to begin to understand 
chlamydial infection in koalas, specific cytokine assays are required. Hence, it is the 
aim of this study to clone and identify the key cytokines in chlamydial disease; IFNγ, 
TNFα, IL10 and IL17A. RT-PCR based assays are to be then developed for these 
cytokines to enable us to quantitate the expression of these cytokines in the koala. 
Under the scope of this study, these assays will be used to analyse cytokine response 
in chlamydial infection and following chlamydial disease in the koala. This study 
will contribute to the limited assays that are currently available to study koala 
immune system. 
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1.2 THE OVERALL OBJECTIVE OF THE STUDY 
The overall objective of the work described in this thesis is to develop real-time PCR 
based assays to understand chlamydial disease pathogenesis in the koala by 
addressing the following specific aims. 
 
1.3 SPECIFIC AIMS OF THE STUDY 
Aim1 - Cloning of selected key cytokine genes in the koala: 
1. Tumour Necrosis Factor α (TNFα) 
2. Interleukin 10 (IL10) 
3. Interleukin 17A (IL17A) 
4. Interferon gamma (IFNγ) 
Aim 2 
DNA sequence and phylogenetic analysis of selected key koala cytokine gene 
sequences. 
Aim 3 
Development of quantitative real-time PCR (RT-PCR) assays to measure cytokine 
response in the koala. 
Aim 4 
Apply the developed RT-PCR assays to quantitate and evaluate cytokine response 
and immunogenicity in healthy, Chlamydia infected koalas and koalas suffering 
from chlamydial disease. 
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1.4 ACCOUNT OF SCIENTIFIC PROGRESS LINKING THE CHAPTERS 
This thesis consists of three papers, which have been accepted/published in peer 
reviewed journals. The scientific work described in these three papers directly 
addresses the specific aims of this study. 
 
The first paper (Chapter 3) is titled ‘Preliminary characterisation of tumor necrosis 
factor alpha and interleukin-10 responses to Chlamydia pecorum infection in the 
koala (Phascolarctos cinereus)’ and has been published in the ‘PLoS One’ journal, 
Volume 8, Issue 3 on March19, 2013. This paper describes the cloning and 
sequencing of partial TNFα and IL10 mRNA sequences which are relatively 
conserved amongst different species. A phylogenetic tree constructed using the Jukes 
Cantor UPGMA tree build method showed clustering of the koala TNFα and IL10 
with other marsupial sequences. qrtPCR based cytokine assays were developed to 
estimate their relative expression in response to chlamydial antigen exposure in a 
group of ten koalas with and without chlamydial disease/ infection. However, in 
order to draw definitive conclusion regarding the role Th1 and Th2 cytokines in 
koala chlamydiosis, it is essential to investigate the expression of the principal Th1 
cytokine, IFNγ, which leads us to the next manuscript describing its sequence 
analyses and expression. 
 
The second paper (Chapter 4) titled ‘Molecular characterisation and expression 
analysis of Interferon gamma in response to natural Chlamydia infection in the 
koala, Phascolarctos cinereus’ has been published in the journal ‘Gene’ Volume 
527, Issue 2 on June 18, 2013. This paper details the mRNA sequence, phylogenetic 
analysis and qrtPCR assay of the koala IFNγ gene and its use in the same cohort of 
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koalas described in Chapter 3. In spite of the general trend observed in the 
expression of TNFα, IL10 and IFNγ in this group of 10 koalas, variations were 
observed in individual animals. In our efforts to minimise these variations, it was 
decided to analyse the gene expression of these cytokines in a larger group of koalas 
the results for which are described in the next manuscript along with the sequence 
analysis and gene expression of IL17A cytokine.  
 
The third paper (Chapter 5) is a manuscript titled ‘Interleukin 17A is an immune 
marker for chlamydial disease severity and pathogenesis in the koala (Phascolarctos 
cinereus)’ and has been accepted for publication in the journal ‘Developmental and 
Comparative Immunology’ on May 22, 2014. This paper details the cloning and 
sequencing of the koala IL17A sequence. The IL17A qrtPCR assay developed as 
part of this investigation was applied to a cohort (n=41) of wild koalas with and 
without chlamydial disease. 
 
1.5 THESIS OUTLINE 
This thesis has been written according to Queensland University of Technology’s 
‘PhD thesis by publications’ guidelines. Chapter 2 describes the literature relevant to 
the field of this study. Chapter 3, 4 and 5 describe published/submitted work in peer 
reviewed journals as part of this project. Chapter 6 is a discussion of the significant 
findings of this project along with a few suggestions for future scientific work in this 
area.  
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2.1 Chlamydial Infections in Koalas 
2.1.1 Koala – Distribution and presence in Australia 
The koala is an arboreal marsupial, native to the Australian forests and woodlands 
predominated by trees of the genus Eucalyptus. It is the last surviving member of the 
family Phascolarctidae and serves as an international icon of Australia’s unique and 
rich biodiversity. The natural home range of the species extends along the eastern 
and south eastern regions of the country, covering Queensland, New South Wales, 
Victoria and certain parts of South Australia and is influenced by altitude, 
temperature and leaf moisture. Throughout most of this animal’s home range, koala 
habitat is undergoing rapid fragmentation as a result of urbanisation and logging, 
inadvertently leading to decline in koala habitat, thus posing a serious threat to the 
survival of the koala (Melzer et al., 2000). A loss of quality habitat for koalas and the 
resulting decline in their numbers has been exacerbated by anthropogenic factors 
associated with urban expansion such as motor vehicle accidents (Dique et al., 2003) 
and dog attacks (Lunney et al., 2007), key processes that have contributed to 
increased koala morbidities and mortalities over the last decades.    
 
In terms of the decline of the koala, previous estimates are that overall koala 
numbers have experienced an at least 50% decline since European settlement 
(Melzer et al., 2000). Before European settlement, indigenous Australians hunted the 
koala extensively leading to a decline in the numbers (Penn et al., 2000). Towards 
the end of the 19th century, a growing international fur market for koala pelts saw 
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large scale commercial hunting of the koala with deaths estimated to be between 
450,000 to nearly one million animals during the period 1906-1927 in Queensland 
alone (Hrdina and Gordon, 2004).  
 
Apart from the above mentioned anthropogenic and natural reasons that have led to a 
decline in the Australian koala population over decades, infectious diseases have also 
been implicated as a serious threat to the survival of the koala. Infections due to 
members of the genus Chlamydia are by far the most important cause of disease 
associated with this wildlife host. Reports of disease manifestations resembling that 
of chlamydiosis, including clinical presentations of cystic ovaries and fallopian 
tubes, cystitis, conjunctivitis and nephritis, can be observed as far back as the early 
20th century (Pratt, 1937; Polkinghorne et al., 2013). However, the aetiology of the 
disease was established only in 1974 when Cockram and Jackson isolated Chlamydia 
using chick embryo yolk sacs from cases of kerato-conjunctivitis in the koala and 
later from genital and nasal sites (Grice and Brown, 1985). 
 
2.1.2 Taxonomy of koala Chlamydiae   
When a chlamydial agent was first cultured from cases of keratoconjunctivitis in the 
koala using chick embryo yolk sac it was classified as C. psittaci owing to its non-
sensitivity to sodium sulphadiazine, compared to C. trachomatis (Cockram and 
Jackson, 1974). With the advent of molecular technologies, it was later realised that 
the C. psittaci isolated from the koala was distinct from C. psittaci isolated from 
other animals (Girjes et al., 1988). It was further established that two distinct strains 
infect the conjunctiva and urogenital tract of the koala and these were assigned as 
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Type I and Type II strains (Girjes et al., 1988). These two strains were later 
designated as C. pneumoniae and C. pecorum respectively based on the nucleotide 
sequence similarity of the ompA gene (gene encoding the major outer membrane 
protein, MOMP) to previously identified strains (Girjes at al., 1994; Glassick et al., 
1996). However, with the reclassification of the members in the order Chlamydiales 
based on the 16S and 23S rRNA genes, the two koala strains, C. pneumoniae and C. 
pecorum were classified into a new genus Chlamydophila (Everett et al., 1999). 
Nonetheless, this rather controversial classification was revisited and based on 
information from whole genome sequence analysis, members of the family 
Chlamydiaceae were reunited back into a single genus, Chlamydia (Stephens et al., 
2009). For the purposes of this thesis, the two chlamydial pathogens of the koala will 
be referred to as C. pneumoniae and C. pecorum as per the latest nomenclature. 
 
2.1.3 Epizootiology 
Chlamydial infections are highly prevalent in the Australian wild and captive koala 
populations. Prior to the 1990s, respiratory, ocular and urogenital chlamydial 
diseases in the koala were thought to be caused by a single species, C. psittaci 
(Cockram and Jackson, 1974; Brown and Grice, 1984a; McColl et al., 1984). While 
early serological studies were unreliable, the use of molecular detection methods 
such as PCR has provided greater insight into the incidence and epizootiology of 
koala chlamydiosis.  
 
While some island populations are reported to be free of chlamydial infection, 
certain koala populations in northern and eastern Australia have infection levels as 
high as 72-100% (Polkinghorne et al., 2013). The first molecular epidemiology study 
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targeting the genus specific Chlamydia ompB PCR and speciation via DNA probe 
hybridisation reported that 73% of animals were infected with C. pecorum and 21% 
were infected with C. pneumoniae in a free range koala population in south-east 
Queensland (Jackson et al., 1999). None of the animals infected with C. pneumoniae 
had any evidence of clinical disease suggesting that C. pecorum was more 
pathogenic of the two infecting strains. More recent evidence of prevalence of the 
chlamydial disease in north east Australian koala populations comes from records of 
wildlife hospital. Chlamydiosis was the second most common reason of koala 
hospital admissions in a koala rehabilitation facility in New South Wales over a 30 
year period (Griffith et al., 2013). Over a period of 10 years, 32% of koala 
admissions in the Australia Zoo Wildlife Hospital, Beerwah, Australia, were due to 
chlamydiosis (Unpublished data, Hospital Records). While these trends of admission 
to the wildlife hospitals could serve as an indication of the prevalence of the disease 
in the wild, the actual picture of infection prevalence could be much higher or lower 
than this as hospital admissions are obviously biased and more often rely on chance 
admission of diseased animals.  
 
There is also evidence of additional Chlamydia- like organisms circulating in wild 
koala populations (Devereaux et al., 2003). These non- C. pneumoniae, non- C. 
pecorum species were seen in co-infections with C. pecorum or C. pneumoniae 
infections in the koala and these novel strains have been termed the Uncultured 
Koala Chlamydiales (UKC). However, their ability to cause disease remains 
unknown. 
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2.1.4 Clinical presentation of koala chlamydiosis 
2.1.4.1 Ocular infection and disease - Keratoconjunctivitis 
Ocular infection may be unilateral or bilateral in the koala, with chronic infection 
usually resulting in a bilateral clinical presentation. Initially, acute cases show a 
slight serous ocular discharge and the eye may be partially or completely closed. If 
left untreated, the signs increase in severity and the discharge becomes increasingly 
mucopurulent and conjunctivae becomes reddened, further leading to swelling of the 
conjunctiva and sub-conjunctival tissue. A dried purulent discharge may gum the 
eyelids together. In severe chronic cases, pannus (vascular thickening of the cornea) 
with increasing corneal opacity develops leading to a pinkish white cornea which is 
completely opaque (Blanshard and Bodley, 2008) (Figure 1).  
 
Figure 1. (A) acute keratoconjunctivitis, showing inflammation of the conjunctiva, 
but minimal conjunctival hyperplasia; (B)chronic, active keratoconjunctivitis, 
showing marked conjunctival hyperplasia and exudation (Image courtesy – Wan et 
al., 2011) 
 
2.1.4.2 Urinary tract infection and disease 
Urinary tract chlamydial infection in the koala may lead to urethritis, cystitis, 
ureteritis and nephritis. It manifests as a brown staining of the rump and tail due to 
incontinence and loss of bladder function leading to constant wetting with urine; 
usually referred to as “wet bottom” or “dirty tail” (Figure 2). In cases of severe 
cystitis, koalas experience discomfort during urination causing vocalisation or crying 
B A 
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owing to the pain (Blanshard and Bodley, 2008). In severe, chronic cases there may 
be alopecia, urine scalding and erythema, skin erosions and ulcerations, secondary 
bacterial and yeast dermatitis of the skin around the urogenital opening, and oedema 
and protrusion of the mucosa of the common vestibule. Sonographically, there is 
mild to marked thickening and irregularity of the bladder wall, reduction in lumen 
diameter, presence of urinary casts and flocculence of the luminal echo. Severe, 
chronic cystitis cases are often associated with extensive loss of bladder mucosa, 
marked loss of functional capacity and chronic haematuria (Polkinghorne et al., 
2013). 
 
Figure 2. Urinary bladder infections leading to “wet bottom” as a result of 
incontinence (Image courtesy - Polkinghorne, et al, 2013) 
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2.1.4.3 Reproductive tract infection and disease 
Both male and female koalas may be affected by chlamydial reproductive tract 
infection and disease. Inflammation of different parts of the reproductive tract may 
result in cystic enlargement of the ovarian bursae, salpingitis, hyforsalpinx, metritis, 
pyometra, vaginitis and pyovagina in the female and prostatitis in the male 
(Blanshard and Bodley, 2008). Diseases of the reproductive tract often go unnoticed 
unless accompanied by urinary tract infection or general debility. Failure to 
reproduce may be the only sign of a reproductive tract disease in females and gross 
pathological changes may be detectable by sonography and/or caudal abdominal 
palpation.  Chronic disease is indicated by cystic changes in the oviducts and ovarian 
bursae and sometimes thickening of the uterine walls (Polkinghorne et al., 2013). 
However, definitive diagnosis of male reproductive tract disease in koalas usually 
relies upon histological examination of tissues collected during necropsy 
examination as sonographic changes are uncommon (Loader, 2010). 
 
Figure 3. Reproductive tract cysts in koala. (a) Bladder (b) Ovarian bursal cysts (c) 
Colon (Image Courtesy – Wan et al., 2011) 
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2.1.4.4 Respiratory tract infection and disease - Rhinitis/Pneumonia  
Atypical presentations such as acute shifting lameness, throat pain and dysphagia, 
epidermal ulceration at pressure points and inflammation of carpal and patellar 
tendons has been observed as part of the clinical spectrum occurring in conjunction 
with upper respiratory tract disease (Blanshard and Bodley, 2008). C. pneumoniae 
infection has been associated with a range of respiratory signs such as difficulty in 
breathing, sneezing and coughing, further leading to serous and often purulent nasal 
discharge (Wardrop et al., 1999).  
 
2.1.5 Koala Chlamydiosis - Diagnosis and treatment  
The principal method of diagnosis during apparent chlamydial disease is veterinary 
evaluation of clinical signs and pathological lesions. Radiological (Brown et al., 
1984b) and ultrasound (Loader, 2010) examinations to determine urinary tract as 
well as reproductive tract cysts and enlargements is used by veterinarians on 
anesthetised koalas. Visual analysis of the muco-purulent discharge from the eyes 
and evidence of opacity serve as indicators of ocular chlamydial disease. Along with 
the veterinary evaluation, Chlamydia culture, antigen and DNA detection have been 
used for diagnosing chlamydial infection in the koalas. 
 
Cockram and Jackson (1974) were the first to culture Chlamydia from cases of 
keratoconjunctivitis in the koala using chick embryo yolk sacs. Reflecting the 
advancements in the field of Chlamydia tissue culture, a tissue culture protocol using 
African green monkey kidney cell lines was established and used to isolate C. 
psittaci serotype 2 strains from cases of koala chlamydiosis (Grice and Brown, 
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1985). However, the culture techniques cannot be used for diagnosis at the point of 
care and are also time consuming and labour intensive procedures which require to 
be performed in research laboratories. 
 
Chlamydial antigen detection tests were later used to circumvent the limitations of 
the culture technique. A field trial evaluating the sensitivity, specificity and 
usefulness of nine antigen detection kits for the diagnosis of chlamydial infection in 
the koala reported Clearview ELISA (Unipath), a solid phase direct antigen detection 
kit, to have 91% sensitivity and 100% specificity in the detection of chlamydial 
antigen (Wood and Timms, 1992). The Clearview test is part of recommended line 
of diagnosis for assessment of chlamydial infection in the koala (Blanshard and 
Bodley, 2008). A recent study has shown Clearview test to be sensitive enough for 
the diagnosis of active chlamydial infection and to have a detection limit of 400 C. 
pecorum copies/µl when compared to PCR, thus making it suitable for a rapid 
diagnosis in the field (Hanger et al., 2013).  
 
PCR has now become the gold standard for the detection of chlamydial infection in 
the koalas. Jackson et al. (1999) first used genus specific Chlamydia ompB PCR for 
the screening of koala populations and species specific DNA hybridisation probes 
for differentiation into C. pecorum and C. pnuemoniae. Genus (Markey et al., 2007) 
and species (Marsh et al., 2011; Wan et al., 2011) specific quantitative real time 
PCRs with detection limits as low as one copy of 16S rRNA/µl are being used today 
to quantify the chlamydial load, correlate it with disease severity and to monitor 
treatment progression. In spite of the advantages, PCR based detection of chlamydial 
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infection in the koala remains limited to research applications as the molecular lab 
facilities required for conducting the same may not be available at the point of care. 
 
The aim of the current treatment regimens for koala chlamydiosis is to release koalas 
capable of reproduction back into the wild. To achieve this outcome, anti-microbial 
therapy in hospitalised koalas includes systemic administration of enrofloxacin 
10mg/kg or chloramphenicol 60mg/kg (Blanshard and Bodley, 2008). Treatment for 
ocular chlamydiosis includes topical antimicrobial therapy and systemic 
administration of drugs. Markey et al. (2007) used 16S rRNA PCR to demonstrate 
that subcutaneous injection of chloramphenicol (Chloramphenicol 150, Delvet Pty. 
Ltd., New South Wales, Australia) administered at a dosage of 60mg/kg for a 
duration of 45 days led to cessation of chlamydial shedding and could not be 
detected 2 weeks post treatment either. However, enrofloxacin has been found to be 
ineffective in the treatment of koala chlamydiosis (Griffith et al., 2010). Antibiotics 
such as erythromycin and oxytetracycline, which are used for the treatment of 
chlamydial infection in other species, are unsuitable in the koalas as they affect the 
gut microflora of the koalas leading to wasting and death (Griffith et al., 2010). Due 
to the complications associated with antibiotic therapy, development of an effective 
anti-chlamydial vaccine for the koalas is important and initial trials using 
recombinant major outer membrane protein have shown promising results (Carey et 
al., 2010; Kollipara et al., 2012; Kollipara et al., 2013). 
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2.2 Chlamydial Developmental Cycle 
Members of the genus Chlamydia are etiological agents of many human and animal 
diseases. Chlamydia is an obligate intracellular bacterium which has a biphasic 
developmental cycle. It alternates between two morphological forms, the elementary 
body (EB) and the reticulate body (RB) (Moulder, 1991). EBs are extra-cellular, 
metabolically inert forms, likened to a “spore-like” form of the organism, 
responsible for dissemination of infection by their ability to attach to and invade 
susceptible cells. Upon infection, EBs are internalized in membrane bound vacuoles 
termed inclusions. EBs differentiate into metabolically active forms, termed RBs, 
and undergo repeated cycles of binary fission leading to secondary differentiation 
back to EBs. EBs are released from host cells via two mutually exclusive pathways, 
lyses and extrusion, releasing EBs that infect neighbouring cells (Hybiske and 
Stephens, 2007). Under stressful growth conditions, imposed by immunological 
responses, antibiotics, or nutrient deprivation, the developmental cycle can be 
disrupted, resulting in the appearance of large, aberrant RBs (Figure 4; Hogan et al., 
2004; AbdelRahman and Belland, 2005). However, Chlamydia has often been 
associated with long term disease or a chronic infectious state. This is possible 
because of the presence of persistent chlamydial forms. Persistence has been defined 
as ‘the long term association between Chlamydia and its host cell in which these 
organisms remain in a viable but culture- negative state’ (Hogan et al., 2004). 
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Figure 4. A schematic representation of the chlamydial developmental cycle (Figure 
adapted from AbdelRahman and Belland, 2005). 
 
2.3 Chlamydial Pathogenesis 
While specific chlamydial factors have been linked to disease pathogenesis, it is 
generally recognised that the host response to infection is the critical factor in the 
development of chlamydial disease. Tissue scarring, which is the hallmark of 
chlamydial disease, is attributed to the variations in host immune response to the 
pathogen as not all infections manifest in disease.  Presently, there are two 
hypotheses that have been postulated to account for the host response and its role in 
chlamydial disease pathogenesis, referred to as (i) the cellular paradigm of 
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chlamydial pathogenesis (Stephens, 2003) and (ii) the immunological paradigm of 
chlamydial pathogenesis (Brunham and Peeling, 1994). 
 
2.3.1 Cellular Paradigm 
Stephens (2003) proposed the cellular paradigm of chlamydial pathogenesis based on 
reports of Chlamydia-infected non-immune epithelial and endothelial cells that elicit 
and initiate inflammatory processes by the secretion of pro-inflammatory 
chemokines and cytokines that are also responsible for the tissue scarring and 
remodelling seen in chronic chlamydial infection. In vitro studies have observed pro-
inflammatory immune responses by Chlamydia infected host epithelial cells being 
initiated and sustained by the secretion of pro-inflammatory chemokines such as 
Interleukin (IL) 8, growth-related oncogene protein-α (GROα), granulocyte 
macrophage colony-stimulating factor (GM-CSF), IL1α and IL6 (Rasmussen et al., 
1997). Furthermore, the cellular paradigm attributes the tissue damage and scarring 
of chronic chlamydial infection to the following observations: (i) upon reinfection, 
the host epithelial cells release chemokines which prime chlamydia-specific immune 
cells thereby amplifying the inflammatory immune response; (ii) cellular 
proliferation, tissue damage and scarring observed during chronic chlamydial 
infection can be attributed to the secretion of tissue growth factors, coagulation 
mediators, apoptosis inhibitors and cell adhesion molecules expressed by the 
infected epithelial cells (Hess et al., 2001). As per the cellular paradigm, chlamydial 
infection of epithelial cells results in production of cytokines and chemokines such 
as IL1, TNFα, IL8, GRO α, granulocyte-macrophage colony stimulating factor (GM-
CSF), and IL6 that lead to subsequent tissue damage. Matrix metalloproteases 
(MMPs) and neutrophils that have been recruited to the site cause extracellular 
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matrix deposition and tissue damage. An IFNγ dominated Th1 response ensues. 
Once the infection is resolved, the inflammation reduces, leaving behind tissue 
damage (Darville and Hiltke, 2010). 
 
2.3.2 Immunological Paradigm 
The principal premise for the immunological paradigm of chlamydial pathogenesis is 
that the T cell responses involved in host defence to chlamydial infection may 
inadvertently lead to tissue damage and scarring. The current explanations of the 
immunological paradigm revolve around two theories; a delayed type 
hypersensitivity (DTH) reaction (Yang, 2001) and molecular mimicry (Bachmaier 
and Penninger, 2005). Whilst Th1 mediated DTH has been associated with 
protection (Yang et al., 1999), Th2 type DTH is linked to immunopathology 
(Holland et al., 1996). Another explanation related to chlamydial infection 
pathogenesis is the mechanism of molecular mimicry. Molecular mimicry is the 
phenomenon which describes the presence of similar protein products coded by 
dissimilar genes, which eventually results in an immune response by the host 
targeted against self and non-self-proteins. Thus far, molecular mimicry has been 
suggested for heat shock protein 60, the DNA primase and the OmcB proteins in 
Chlamydia (Bachmaier and Penninger, 2005). These proteins have been shown to 
mimic human endogenous proteins and could activate antibodies and T cells targeted 
against Chlamydia and cause tissue damage and sequelae in the host (Morrison, 
1991).  
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Evidence for both these paradigms at work can be seen in animal models of 
chlamydial infection, as well as in humans. It is also to be noted that all incidents of 
chlamydial infection do not exclusively result in the damaging and irreversible 
disease sequelae. Hence, additional microbiological as well as host factors probably 
also play a role in chlamydial disease pathogenesis. For instance, polymorphisms in 
γα and IL10 promoter genes are known to effect human immune response to 
Chlamydia trachomatis infection (Conway et al., 1997; Ohman et al., 2006). Also, 
variations in chlamydial strains could be responsible for the varied pathology 
observed in the population (Byrne, 2010). Hence, it would suffice to surmise that the 
pathology of members of the genus Chlamydia is an outcome of complex 
interactions between a multitude of host and pathogen factors and none can be 
analysed in isolation.  
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2.4 Cytokines 
Meagre (1991) defines cytokines as ‘a class of inducible, water-soluble, 
heterogenous proteinaceous mediators of animal origin of molecular weight greater 
than 5000 that exercise specific, receptor- mediated effects on target cells and/or in 
the mediator- producing cells themselves’. A general understanding of the key 
cytokines involved in chlamydial infection and their specific role in chlamydial 
infection is necessary to evaluate their production in the koala.  
 
2.4.1 Tumour Necrosis Factor Alpha (TNFα) - TNFα is a trimeric pro-
inflammatory polypeptide synthesised principally by macrophages in response to 
bacterial toxins, inflammatory products and other invasive stimuli (Tracey and 
Cerami, 1994; Bradley, 2008). It was once referred to as an ‘all-category champion’ 
because of the spectrum of biological activities triggered by the direct and indirect 
actions of systemic TNFα exposure (Vassali, 1992). The biological effects of acute, 
high-dose systemic exposure differ from the effects of repeated exposure to lower 
doses of TNFα. When acute exposure to high doses of TNFα results in shock and 
tissue injury, chronic exposure leads to cachexia and tolerance (Pfeffer, 2003). TNFα 
is also a pivotal mediator of inflammation that activates leukocytes, enhances 
adherence of neutrophils and monocytes to endothelium, promotes migration of 
inflammatory cells into intercellular matrix, stimulates fibroblast proliferation and 
triggers local production of other proinflammatory cytokines. These inflammatory 
actions of TNFα contribute to the localization and walling off of infections (Tracey 
and Cerami, 1994). However, recently TNFα inhibitors have been demonstrated to 
be effective in the treatment of immune mediated diseases such as rheumatoid 
arthritis, psoriasis and spondylitis (Palladino et al., 2003; Silva et al., 2010). 
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Activated macrophages stimulated by lipopolysaccharide (LPS) are the largest 
source of TNFα (Baer et al., 1998). Conversely, monocytes and macrophages which 
are one of the main targets of TNFα are strongly activated and differentiated by 
TNFα (synergised by IFNγ) resulting in further TNFα release. The activated 
macrophages in turn trigger two cytotoxic pathways; the superoxide pathway 
producing reactive oxygen intermediates and the nitric oxide pathway producing 
reactive nitrogen intermediates (Aggarwal et al., 2012). These two pathways are 
triggered by IFNγ and to a lesser extent by TNFα, which however strongly 
synergises with IFNγ (Suk et al., 2001; Cavalcanti et al., 2012). This mechanism 
could be responsible for the parasiticidal and bactericidal effect of TNFα (Ding et al., 
1988; Drapier et al., 1988). However, the overall biological effect of this cytokine 
may be primarily determined by the body compartment in which it is produced 
(Tracey et al., 1990). TNFα is also known to be a pyrogen (Dinarello et al., 2004), 
play a role in sleep regulation (Baracchi and Opp, 2008) and development of 
endotoxic shock (Ashkenazi et al., 1991). 
 
TNFα has been demonstrated to be produced in response to chlamydial infection. 
Expression of TNFα in a host is associated with both host defence and pathological 
sequelae associated with chlamydial infection.  High levels of TNFα secretion have 
been observed during the early days of primary infection, the intensity of which was 
dependent on the intensity of infection (Darville et al., 1995). However, its 
contribution to resolution of infection was found to be mouse-strain dependent 
(Darville et al., 1997).  Contrastingly, TNFα produced by CD8+ T cells has been 
shown to mediate hydrosalpinx (accumulation of clear serous fluid in the oviduct) 
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following primary genital C. muridarum infection in a mouse model (Murthy et al., 
2011). This study also demonstrated that clearance of primary genital tract infection 
is not dependent on TNFα. Similarly, Kamalakaran et al. (2013) demonstrated that 
the absence of TNFα did not alter the resolution of primary or secondary vaginal 
infection but contributed to reduction of upper genital tract pathology in a mouse 
model of intravaginal C. muridarum infection.  Nonetheless, in a recent vaccine 
study, protection against C. muridarum genital tract infection following intranasal 
vaccination with live/dead C. muridarum was afforded only in the presence of T 
cells coexpressing IFNγ and TNFα suggesting their role as optimal effector cells in 
protective immunity (Yu et al., 2011). In a mouse model of pneumonia caused by C. 
trachomatis, TNFα antigen and bioactivity were demonstrated in vivo in the lungs of 
an athymic (nude) and heterozygous (nu/+) mice. These mice were rendered more 
susceptible to mortality upon administration of antibody to TNFα (Williams et al., 
1990). Elevated TNFα levels have been associated with conditions such as 
atherosclerosis and coronary heart disease resulting from C. pneumoniae infection 
(Schumacher et al., 2002; Campbell et al., 2005).  However, no studies have yet 
described the role of TNFα in C. pecorum infection nor in the koala and this project 
would be first to investigate this, to the best of our knowledge. 
 
2.4.2 Interleukin 10 (IL10) - IL10 is a dimeric polypeptide secreted by cells of the 
innate and adaptive immune system, including dendritic cells, macrophages, mast 
cells, natural killer cells, eosinophils, neutrophils, T regulatory (Treg) cells, CD4 and 
CD8 T cells and B cells and belongs to the IL10 family of cytokines (Maloy and 
Powrie, 2001; Moore et al., 2001; Fillatreau et al., 2002; Roncarolo et al., 2006; 
O'Garra and Vieira, 2007;  Trinchieri, 2007; Maynard and Weaver, 2008; Sabatos-
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Peyton et al., 2010; Ouyang et al., 2011; Mauri and Bosma, 2012). Production of 
IL10 was first described in Th2 cells (Fiorentino et al., 1989; Ouyang et al., 2011), 
however, it is also produced by Th1 cells in humans but requires a strong activation 
and the presence of IL12 to be co-expressed with IFNγ (Prete et al., 1993; Saraiva 
and Garra, 2010). 
 
The principal function of IL10 appears to be to limit and ultimately terminate 
inflammatory responses (Moore et al., 2001). IL10 inhibits the activation and 
effector functions of T cells, monocytes and macrophages (Fiorentino et al., 1989; 
Ng et al., 2013). IL10 mediates its function by targeting activated and resting 
macrophages. It down regulates the expression of major histocompatability complex 
class II (MHC II) proteins on the surface of target macrophages and suppresses the 
activation of reactive oxygen and nitrogen intermediates in activated macrophages, 
thereby limiting the capacity of innate immune cells to kill pathogens (Bogdan et al., 
1991). IL 10 also inhibits the secretion of pro-inflammatory cytokines, such as IFNγ, 
TNFα, IL1, IL2 as well as several chemokines (Bogdan et al., 1991; Ouyang et al., 
2011). 
 
Up-regulated IL10 production has been indicated to play a critical role in chronic 
infectious diseases and their complications (Arababadi et al., 2010; del Rio et al., 
2013). Absence of IL 10 can be accompanied by an immunopathology which is 
detrimental to the host. It acts on dendritic cells and macrophages, inhibiting the 
development of a Th1 type response. It induces anti-inflammatory responses 
mediated through the IL10 receptor and activation of signal transducer and activation 
of transcription 3 (STAT3) (reviewed in (Moore et al., 2001). However, the 
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mechanism which regulates the production of IL10 varies in different IL10 
producing immune cells (Saraiva and O’Garra, 2010). 
 
The role of IL10 in chlamydial infection has been demonstrated in a number of 
models. C. pneumoniae infection in IL10 knockout mice led to an early and 
accelerated clearance of infection compared to the control wild type mice (Penttila et 
al., 2008). However, the IL10 KO mice exhibited severe inflammatory response in 
the lungs following infection as well as demonstrated higher levels of 
proinflammatory cytokines in the intrapulmonary region when compared to the wild 
type mice. On similar lines, Geng et al. (2000) confirmed the role of IL10 by 
studying its role in C. pneumoniae infection of human PBMCs, where it was found 
to play an anti-inflammatory function by down-regulating pro-inflammatory 
cytokines such as IL12 and TNFα. Igietseme et al. (2000) demonstrated in an 
intravaginal model of C. trachomatis agent of mouse pneumonitis (C. muridarum) 
that IL10-/- mice were highly resistant to genital tract infection as antigen presenting 
cells (APCs) preferentially activate a Th1 response which express pro-inflammatory 
cytokines involved in chlamydial immune response. Similar effects of IL10 on pro-
inflammatory cytokines such as TNF, IL6 and IL8 when HeLa cells and mouse 
macrophages are exposed to live or dead C. trachomatis were observed (Yilma et al., 
2012). A similar effect has also been observed in the female lower genital tract, 
where survival of C. trachomatis was favoured by enhanced secretion of IL10 
leading to diminished Th1 response (Marks et al., 2010). Recently, it has also been 
posited that the immune response to human genital chlamydial infections is 
principally maintained by Type 2 immune response that minimises 
immunopathological damage to the host (Miguel and Cherpes, 2012).   
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2.4.3 Interferon gamma (IFNγ) - IFNγ is a homodimeric pleiotropic cytokine 
secreted mainly by Th1 helper T cell subset and regulates immune and inflammatory 
processes in the body (Farrar and Schreiber, 1993). It is also produced by CD8+ T 
cells, mucosa associated invariant (MAI) T cells, NK-T cells, certain Innate 
Lymphoid Cells (ILCs) and NK cells (Schoenborn and Wilson, 2007). IFNγ is first 
detectable 6-8 hours after T cell stimulation and peaks at 12-24 hours in humans.   
 
IFNγ is the primary cytokine responsible for nonspecific cell mediated immune 
mechanisms of host defence. It exerts its pleiotropic effect by its interactions with its 
specific receptor present on the surface of all cells, except erythrocytes. Its principal 
function is to act as a macrophage activating factor (Schroder et al., 2004), however, 
it also increases the expression of MHC class I (Zhou, 2009) and class II antigens 
(Mach et al., 1996; Thelemann et al., 2014) on the surface of immune cells thereby 
increasing the recognition of foreign antigens. This property of IFNγ is enhanced by 
the synergistic effect of TNFα (Meagre et al., 1991; Suk et al., 2001; Cavalcanti et 
al., 2012). IFNγ also induces the production of enzymes involved in tryptophan 
metabolism such as indoleamine 2,3-dioxygenase (IDO) and tryptophanyl - tRNA 
synthetase (Pferfferkon, 1984; Schrocksnadel et al., 2006). Tryptophan depletion in 
the cell by these enzymes inhibits the growth of intracellular parasites in human cells 
(Murakami et al., 2012). 
 
The role of IFNγ in chlamydial disease pathology is well documented through 
studies carried out in IFNγ -/-, IFNγ receptor -/- mice or mice treated with anti-IFNγ 
antibodies. In the absence of IFNγ or IFNγ receptor, chlamydial infection with C. 
muridarum was prolonged compared to the wild type mice. Also, dissemination of 
 37 
 
infection to distal body parts was observed in the absence of IFNγ, suggesting a role 
for IFNγ in containing the infection at its primary site (Cotter et al., 1997; Johansson 
et al., 1997; Ito and Lyons et al., 1999; Rottenberg et al., 2000). However, Perry et 
al. (1999) demonstrated that there was a difference in sensitivity to the direct 
inhibitory actions of IFNγ between human and murine strains of C.trachomatis; the 
human serovar being more sensitive than the murine when species specific IFNγ was 
used.  
 
The principal mechanism by which IFNγ is thought to inhibit chlamydial replication 
in human host cells is by depleting the tryptophan reserves through activating the 
indoleamine 2, 3-dioxygenase (IDO) pathway, which converts L-trptophan to N-
formylkynurenine (Beatty et al., 1994). In the mouse host IFNγ induces p47 
GTPases and not IDO to inhibit lipid scavenging by the chlamydial inclusion 
(Nelson et al., 2005). IFNγ has also been observed to mediate deprivation of iron in 
the cell resulting in control of chlamydial infection (Al-Younes et al., 2001; Freidank 
et al., 2001). Further, the production of toxic compounds such as nitric oxide which 
are detrimental to chlamydial growth, are mediated by IFNγ (Ramsey et al., 2001). 
However, the inflammatory response that results from localised IFN gamma 
production is thought to be the cause of the tissue scarring seen in chlamydial 
disease. Moreover, a primary immune response is hypothesised to not be adequate to 
produce the reaction and it is only after repeated cycles of immune response that a 
disease presentation such as conjunctivitis or salpingitis develops (Rottenberg et al., 
2002; Entrican et al., 2004).  
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2.4.4 Interleukin 17A (IL17A) 
IL17A is a pro-inflammatory cytokine secreted by Th17 T helper cell population 
(Infante-Duarte et al., 2000; Kimura et al., 2007). It is also known to be produced by 
other cells such as αβ T cells, γδ T cells, invariant Natural Killer T cells (iNKT) 
cells, Lymphoid Tissue inducer (LTi)-like cells, NK cells, MAIT cells, ILC3 cells 
and macrophages (Cua and Tato, 2010; Jin and Dong, 2013).  
 
The mechanism of action of IL17A is through the generation of pro-inflammatory 
cytokines and chemokines, which in turn attract the neutrophils and macrophages to 
the site of inflammation (Jin and Dong, 2013). It is known to play a protective role in 
the defense against pathogens at epithelial and mucosal surfaces. It is involved in the 
clearance of infections caused by extracellular bacteria such as Klebsiella 
pneumoniae (Happel et al., 2005) and Staphylococcus aureus (Cho et al., 2010 ) as 
well as intracellular bacteria such as Mycobacterium tuberculosis (Lockhart et al., 
2006), Listeria monocytogenes (Hamada et al., 2008) and Salmonella typhimurium 
(Raffatellu et al., 2008). IL17A is also required for controlling fungal infections such 
as Pneumocystis carinii and Candida albicans (Rudner et al., 2007). However IL17A 
is also known to have a role on autoimmunity (Marwaha et al., 2012) and 
inflammation (Ouyang et al., 2008) as excessive IL17A can lead to enhanced pro-
inflammatory cytokine expression and chronic inflammation resulting in tissue 
damage. IL17A has been shown to aid Th1 immunity development and neutrophil 
recruitment (Scurlock et al., 2011, Weaver et al., 2013). IL17A and IFNγ have been 
shown to a have synergistic effect on the up-regulation of iNOS and NO production 
(Zhang et al., 2012) and have opposing functions when it comes to neutrophil 
recruitment (Savarin et al., 2012). 
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The role of IL17A in chlamydial immunity has only been recently investigated. As 
members of the genus Chlamydia have a biphasic lifecycle with an intracellular and 
extracellular phase, the role played by IL17A in chlamydial disease pathogenesis is 
of interest. However, so far IL17A has not been shown to have a direct role in 
chlamydial infection (Zhang et al., 2009). Instead, IL17A has been shown to play an 
important role against chlamydial infection through neutrophil recruitment and 
promotion of protective Th1 immunity (Scurlock et al., 2011). In the pulmonary 
model of C. muridarum infection, antibody-mediated neutralisation of IL17A caused  
greater weight loss, higher organism growth and severe pathological changes in the 
lung compared to the control mice (Bai et al., 2009). These IL17A neutralised mice 
showed a weaker Th1 response and lesser neutrophil recruitment compared to the 
control mice. IL17A secretion in conjunction with IFNγ has been found to induce 
enhanced resolution of chlamydial genital tract infection following immunisation 
(Yu et al., 2010). This finding was replicated in a recent study where elevated 
expression of IL17A cytokines and receptors in the oviduct of immunised mice 
correlated with early clearance of upper genital tract infection (O’Meara et al., 
2013a). It plays a similar role in protection following pulmonary challenge after 
immunisation (O’Meara et al., 2013b). Nonetheless, IL17A secretion has also been 
associated with the development of immunopathology (Andrew et al., 2013; Lu et 
al., 2012; O’ Meara et al, 2013a). Also, a recent study in humans has reported strong 
expression of IL17A in women suffering from chlamydial cervicitis (Jha et al., 
2011). Given the pathogenic relevance of IL17A, it is important to investigate its 
role in koala chlamydiosis.   
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2.5 Marsupial Immunology 
 
Metatherians (marsupials) comprise one of the three major groups of mammals and 
are the closest related group to the eutherian (placental) mammals. Metatherians and 
eutherians are thought to have diverged 180 million years ago (Kumar and Hedges, 
1998). The major difference between these two mammalian groups is the mode of 
reproduction and that metatherians give birth to relatively immature offsprings, 
which undergo further development within the pouch or marsupium of the mother. 
Also, the immune response in the adult was believed to be slower and less 
accentuated than the placental mammals (Jurd, 1994). The recent whole genome 
sequencing of three marsupial species, namely, short-tailed opossum (Mikkelsen et 
al., 2007), tammar wallaby (Renfree et al., 2011) and Tasmanian devil (Murchison et 
al, 2012) has contributed to our understanding of the marsupial immunology and has 
found it to be as complex as that of the eutherian mammals. 
 
2.5.1 Humoral Immunity 
From the early serological studies performed in this field, it was understood that the 
major immunoglobulin (Ig) classes that are present in eutherians (IgG, IgA, IgM, 
IgE) are present in the marsupials as well. An IgA like molecule was identified and 
isolated from tears, milk, urine and gut of quokkas (Well et al., 1974). This molecule 
was found to resemble the immune properties and characteristics of the eutherian 
species. Further research carried out in quokkas revealed the presence of IgG and 
IgM as well (Thomas et al., 1972; Bell et al., 1974).  
 
The presence of immunoglobulins in the marsupials was further confirmed by the 
molecular isolation of marsupial immunoglobulins. The cDNA encoding brushtail 
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possum IgA heavy chain was isolated (Belov et al., 1998). Similar work on 
Australian and American brush tail possum lead to the isolation of IgM heavy chain 
cDNA (Belov et al., 1999). The amino acid sequence comparison of eutherian and 
marsupial IgM cDNA sequences exhibited a high degree of conservation. Another 
study (Aveskogh and Hellman, 1998) which analysed the cDNA of IgG, IgA and IgE 
in Monodelphis domestica and compared it with other placental mammals found a 
high degree of homology and evolutionary relationship between marsupial and 
eutherian immunology. So far no IgD immunoglobulin has been reported for any 
marsupial species. An analysis of the grey short-tailed opossum genome for 
immunoglobulin heavy and light chains showed an absence of IgD. It is postulated 
that an insertion of repetitive elements could have resulted in this gene loss (Wang et 
al., 2009) 
 
Along with developing an understanding of marsupial immunology, study of 
immunoglobulins has also been a tool to understand the evolutionary relationship 
between prototherians, metatherians and eutherians. These molecular findings also 
confirmed the fact that there is a high degree of conservation in the immunoglobulin 
genes i.e. they exhibit a high degree of alignment between the prototherians and 
eutherians (Miller, 2010). However, analysis of the heavy and light chains of the 
immunoglobulin molecule reveals features unique to the marsupials. Unlike the 
eutherians, the marsupial species studied so far have limited heavy chain diversity, 
but complex light chain diversity (Baker et al., 2005a). 
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2.5.2 Cell Mediated Immunity  
Cloning of marsupial T cell receptors (TCR) from Australian and American brush 
tail possums (Zuccolotto et al, 2000) has revealed a high degree of conservation of 
the TCR α and β genes between the marsupials and the eutherian counterparts. 
However, the isolation and identification of TCRδ gene from northern brown 
bandicoot and tammar wallaby revealed multiple and highly divergent genes, which 
is not the case in many eutherian mammals (Baker et al., 2005b). The presence of 
this unique TCRδ gene may be indicative of its significant role in marsupial 
immunology. Also, of interest is the isolation of a novel TCRµ gene from the grey 
short tailed opossum, northern brown bandicoot and the tammar wallaby, which is 
absent in eutherian mammals such as the commonly studied humans and mice. This 
is indicative of the fact that even though the marsupial immunology is more or less 
similar to the eutherians, there could be features which are unique to the marsupials. 
These distinctive immunological features could be necessary for the specific 
immunological needs of the genus (Parra et al., 2007).  
 
The study of MHC class I genes conducted in marsupial species, (red necked 
wallaby, koala and the North American opossum), has revealed that the MHC class I 
loci of marsupials and eutherians are derived from different and independent 
ancestral genes and are not homologous to classical MHC class I (Mayer et al., 1993; 
Houlden et al., 1996; Miska and Miller, 1999). However, studies conducted in 
Monodelphis domestica to understand and evaluate MHC class I responses to 
allogeneic and xenogenic transplantations revealed that they rejected these 
transplants in a method similar to eutherian mammals, although more slowly than 
eutherian mammals (Infante et al., 1991; Stone et al., 1998). These findings are also 
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a pointer towards the high degree of MHC class I polymorphisms present in 
marsupials. Hence, in spite of different ancestral genes, the function of MHC class I 
is similar to that of the eutherians except for the notable exception of a weak and 
delayed MHC class I response.  
 
DA, DB, DC and DM are the four MHC class II gene families that have been defined 
in the marsupial species (Cheng et al., 2010). The copy number of DA and DB genes 
vary greatly between marsupial species as a result of species specific expansion. DA 
and DB genes are distinct from the eutherian class II molecules (Belov et al., 2004) 
whereas DM genes are orthologous to the eutherian DM genes and have been 
reported in grey short-tailed opossum (Gouin et al., 2006) and tammar wallaby 
(Siddle et al., 2009). DC MHC class II genes which are specific to marsupials have 
only been identified in the opossum so far (Belov et al., 2006). Studying the MHC 
diversity serves as a tool to estimate the immunological fitness of a particular 
population with low diversity being linked to greater disease susceptibility. In the 
Tasmanian devil, both MHC class I and II diversity is low which might explain their 
high susceptibility to Devil Facial Tumour Disease (Siddle et al., 2007). 
 
Using genomic or cDNA studies, a large and extensive number of cytokines of the 
Th1, Th2, Th17 and Treg CD4+ subsets have been identified in short-tailed 
opossum, tammar wallaby and Tasmanian devil (Belov et al., 2013) and the brushtail 
possum (Wedlock et al., 1996, 1998, 1999; Young et al., 2012). These have been 
listed in the immunome database for marsupials and monotremes (Wong et al., 
2011). The physiological effects of very few of these cytokines has been studied, 
however, what work that has been completed has shown similar effects to that 
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described for mammalian species. Wedlock et al., (1996) observed that in the 
brushtail possum, bacterial LPS induces transcription of TNFα mRNA similar to 
other mammals. Furthermore, intravenous administration of IL1β in the brushtail 
possum affects its haematology (Wedlock et al., 1999) similar to the observations in 
sheep (Rothel et al., 1998). In vitro expression of brushtail possum IL2 (Young et al., 
2012), as well as tammar wallaby IL6 (Alsemgeest et al., 2013) and IL1β (Young 
and Harrison, 2010), have been found to be similar to other mammals when cultured 
under similar conditions. However, no studies have so far looked at the functional 
role of the identified cytokines in response to a microbial infection/disease. The 
above listed findings in an in vitro environment could be an indicator of analogous 
immunoregulatory pathway similar to the eutherians in these marsupial species. 
 
The availability of genomic sequence of three marsupial species, short-tailed 
opossum, tammar wallaby and Tasmanian devil, has made possible the cloning and 
sequencing of conserved as well as divergent sequences such as the IL4 in tammar 
wallaby (Young, 2011) and IL2 in brushtail possum (Young et al., 2012) using 
degenerate primers designed along conserved areas of respective marsupial cytokine 
sequence alignment. High levels of sequence conservation can be observed amongst 
marsupial species. For example, sequence similarity ranging between 75-90% can be 
observed for cytokines such as TNFα, IL10, IFNγ and IL17A between different 
marsupial species. Whereas the sequence similarity for the same cytokines ranges 
between 60-70% when the marsupial sequences are compared to other mammalian 
cytokine sequences. Evidence of T cell immune capacity has been demonstrated in a 
number of marsupials (Reviewed in (Belov et al., 2013)). Studies conducted in the 
opossum and koala have indicated the absence of a mixed lymphocyte reaction in 
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these marsupials indicating differences in T cell response from their eutherian 
counterparts (Infante et al., 1991; Wilkinson et al., 1992).   
 
2.6 Koala Immunology 
Despite the important position occupied by the koala in Australian culture and 
wildlife, the immunology of this iconic marsupial has had little research and 
analysis. The pioneering work on koala immunology was carried out by Wilkinson et 
al. (1991). The study involved identifying an antibody response in koalas without 
any further characterisation of the Ig molecule involved (Wilkinson et al., 1991). 
This study found that koala immunoglobulins have a higher net negative charge than 
seen in most other mammals. In a similar study (Wilkinson et al., 1992), it was 
suggested that koalas are immunologically lazy. The study demonstrated an initial 
antibody response as late as 12 weeks and also a delayed type hypersensitivity 
reaction which took quite long (12 weeks) to develop. This finding (Wilkinson et al., 
1994) was confirmed with the use of sensitive enzyme immune assays which 
suggested that the humoral  immune response seen in koalas is actually slow when 
compared to the eutherian mammals. However, the study found that the cell-
mediated immune response in koalas was comparable to non-metatherian mammals. 
It was demonstrated that the level and timing of in vitro antigen specific lymphocyte 
proliferative response in koalas sensitised with Bacillus Calmet-Guerin (BCG) was 
comparable to non-metatherian mammals.  
 
Following the identification of B cells and macrophages, koala T lymphocytes were 
identified using an anti-human CD3 antibody (Wilkinson et al., 1995). This antibody 
was found to have a broad cross species reactivity. It was used to label koala T cells 
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from peripheral blood. Similarly, another finding (Wilkinson et al., 1992) during the 
efforts to develop methods for in vitro culture of mononuclear cells from the 
peripheral blood of koalas led to an understanding that koalas showed weak or non-
existent mixed lymphocyte reactions. However, recent studies which tested a multi 
sub-unit chlamydial vaccine in koalas found significant humoral and cell-mediated 
immune reactions elicited towards the antigens that were used in the study (Carey et 
al., 2010; Kollipara et al., 2012; Kollipara et al., 2013). This finding raises questions 
regarding the claims of the koala as being an immunologically sluggish animal and 
this phenomenon needs to be explored further.  
 
Not many studies have looked at the immune response to chlamydial infection in the 
koala. Early studies attempted to use cross reacting species/non-species specific 
assays such as anti-bovine IFNγ, anti-bovine IL4, rabbit anti-koala IgG, sheep anti-
marsupial IgA and IgE to understand the host response to chlamydial infection 
(Higgins et al., 2004; Higgins et al., 2005). These assays exhibited high variability 
and have not subsequently been used in any further studies. In the absence of 
cytokine assays and other immune cell markers, these studies could not establish the 
role played by Th1 and Th2 cells in the pathogenesis of chlamydiosis in the koala. 
Prior to the commencement of this study, no cytokine information was available for 
this host. It is only recently that any progress has been made in this field (Maher et 
al., 2014; Morris et al., 2014).   
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ABSTRACT 
Debilitating infectious diseases caused by Chlamydia are major contributors to the 
decline of Australia’s iconic native marsupial species, the koala (Phascolarctos 
cinereus). An understanding of koala chlamydial disease pathogenesis and the 
development of effective strategies to control infections continue to be hindered by 
an almost complete lack of species-specific immunological reagents. The cell-
mediated immune response has been shown to play an influential role in the response 
to chlamydial infection in other hosts and, as such, the objective of this study was to 
provide preliminary data on the role of two key cytokines, pro-inflammatory tumour 
necrosis factor alpha (TNFα) and anti-inflammatory interleukin 10 (IL10), in the 
koala Chlamydia pecorum response. Utilising sequence homology between the 
cytokine sequences obtained from several recently sequenced marsupial genomes, 
this report describes the first mRNA sequences of any koala cytokine and the 
development of koala specific- TNFα and IL10 real-time PCR assays to measure the 
expression of these genes from koala samples. In preliminary studies comparing wild 
koalas with overt chlamydial disease, previous evidence of C. pecorum infection or 
no signs of C. pecorum infection, we revealed strong but variable expression of 
TNFα and IL10 in wild koalas with current signs of chlamydiosis. The description of 
these assays and the preliminary data on the cell-mediated immune response of 
koalas to chlamydial infection paves the way for future studies characterising the 
koala immune response to a range of its pathogens while providing reagents to assist 
with measuring the efficacy of ongoing attempts to develop a koala chlamydial 
vaccine.  
 
 Keywords:  Koala, cytokine, immune response, RT-PCR, Chlamydia 
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INTRODUCTION 
The koala (Phascolarctos cinereus) is an Australian arboreal marsupial and the last 
surviving member of the family Phascolarctidae. Despite enjoying a unique position 
in Australian culture, the koala faces the threat of localised extinction in many 
regions along the Australian eastern seaboard [1, 2, 3]. The recognition of this 
decline has recently lead to its inclusion in the threatened species list by the 
Australian Government Department of Sustainability, Environment, Water, 
Population and Communities [4]. Several threats are contributing to this decline, 
including habitat destruction [1], natural disasters [5], dog attacks [6] motor vehicle 
accidents [7] and disease. Of the many threatening processes affecting the koala, 
infectious diseases appear to have the greatest impact with a recent study showing 
that if diseases in this host could be reduced by up to 50%, then declining koala 
populations had the potential to be stabilised [8]. 
 
Chlamydia pecorum is the main aetiological agent of infectious disease in the koala 
with studies reporting around 60-98% prevalence of chlamydial infection in certain 
free range koala populations [9, 10, 11, 12]. C. pecorum infection in koalas has been 
associated with cystitis, proliferative conjunctivitis and chronic, fibrotic disease of 
the urogenital tract leading to infertility and death [13, 14, 15, 9, 16, 12]. In non-
koala hosts, the role of cell mediated immunity (CMI) as the major immune response 
generated by the host against chlamydial infection is acknowledged [17, 18, 19]. 
Inflammation, driven by the effects of inflammatory cytokines, has also been linked 
to the manifestation of disease [20].  
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A major hurdle in our understanding of the role of the koala immunological response 
in relation to these diseases is the paucity of immunological reagents for this host. In 
their absence, current assays employed to characterise the marsupial immune 
response rely on reagents from placental mammals, which exhibit only weak cross-
reactivity in marsupial systems [21]. The ideal targets for measuring local and 
systemic immune response to intracellular pathogens are cytokines; soluble immune 
regulators produced by cells of both the innate and adaptive immune systems. In this 
study, we aimed to develop koala-specific assays and perform preliminary studies on 
the expression of two key cytokines, pro-inflammatory cytokine, TNFα, as well as a 
key anti-inflammatory cytokine, IL10. TNFα is a trimeric pro-inflammatory 
polypeptide synthesised principally by macrophages in response to bacterial toxins, 
inflammatory products and other invasive stimuli [22]. IL10 is a dimeric polypeptide 
secreted by cells of the innate and adaptive immune system, the main function of 
which is to limit and ultimately terminate inflammatory responses [23, 24]. The 
partial sequence of a house-keeping gene, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), was also determined for use as an internal control. 
Quantitative, real time (qrtPCR) assays were then developed to measure these two 
key cytokines within koala peripheral blood mononuclear cells (PBMCs) revealing 
strong expression in koalas with current signs of chlamydial disease. 
 
MATERIALS AND METHODS 
Ethics statement 
The collection of blood samples from koalas admitted to Australia Zoo Wildlife 
Hospital, Beerwah was performed by qualified veterinarians. Blood was collected 
from all animals following anaesthesia for other routine veterinary procedures and 
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treatment. The collection and subsequent analysis of these koala blood samples was 
approved by the Queensland University of Technology Animal Ethics Committee 
(Approval No. 0700000845). 
 
Bioinformatics analysis of koala cytokine sequences 
Multiple sequence alignments were carried out using the Geneious Alignment 
program in the Geneious Pro 5.6.5 software and GeneDoc version 2.7.000 software. 
Phylogenetic trees were constructed using Jukes Cantor, UPGMA tree build method 
in Geneious Pro 5.6.5 software. TNFα and IL10 sequences were obtained from 
GenBank (GenBank ID): brushtail possum IL10 (AF026277), North American 
opossum IL10 (XM_003340167), mouse IL10 (M37897), sheep IL10 (Z29362), deer 
IL10 (U11767), horse IL10 (EU438771), cat IL10 (AF060520), monkey IL10 
(DQ890063), human IL10 (AY029171), dog IL10 (NM_001009209), chicken IL10 
(AY647438), Pigeon IL10 (AB618540), brushtail possum TNFα (AF016102), North 
American opossum TNFα (AJ286832), tammar wallaby TNFα (AF055915), red 
kangaroo TNFα (AJ286833), mouse TNFα (EU682384), sheep TNFα 
(NM_001024860), deer TNFα (U14683), horse TNFα (NM_001081819), cat TNFα 
(NM_001009835), monkey TNFα (DQ902477), human TNFα (AB451492), dog 
TNFα (NM_001003244) and chicken TNFα (AY765397). 
 
Sample collection 
PBMCs were harvested from koala blood samples for use in this study. 5-6 ml of 
blood was collected in 6 ml EDTA blood tubes from koalas brought into the hospital 
and stored at 4oC until further processing on the same day. Swabs were collected 
from the conjunctiva of the left eye, right eye, urogenital sinus (females) and urethra 
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(males) using aluminium shafted cotton tipped swabs (Copan, Interpath Services, 
Melbourne).  
 
Koala lymphocyte stimulation assay 
PBMCs from the blood samples were separated using Ficoll Paque gradient 
centrifugation at 400g for 20 mins (GE Healthcare, Rydalmere, Australia). After 2-3 
washings with PBS, the cells were suspended in 1 ml of RPMI 1640 T cell media, 
supplemented with 5% foetal calf Serum, antibiotics and β-mercaptoethanol (0.001 
M). The cells were then diluted to a concentration of 2×106 cells/ ml in the media 
and mixed with an equal volume of T cell mitogens, PMA (1 µg/ ml) and Ionomycin 
(50 ng/ ml) to stimulate koala PBMCs. To optimise the target gene expression, 
PBMCs were stimulated for different durations of time (24, 48 and 72 hours). 
 
The cell suspension and mitogen were added at a 1:1 concentration for a final 
volume of 200 µl/ well to standard 96-well microtitre plates (Nunc) and incubated at 
37oC in 5% CO2. At the end of the incubation period, cells were harvested from the 
cell suspension by centrifugation at 400g for 10 mins and suspended in 1 ml of 
Trizol reagent (Invitrogen, Victoria, Australia) and left at room temperature for 5 
mins to homogenise. Samples were then stored at -80oC for downstream 
applications. 
 
RNA extraction and reverse transcription 
RNA extraction was performed from the PBMCs suspended in Trizol reagent using 
the RNeasy Mini Kit (Qiagen, Victoria, Australia) according to the manufacturer’s 
instructions. The concentration and purity of RNA was determined using a Nanodrop 
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ND-1000 Spectrophotometer. RNA degradation was checked by running the sample 
on a 2% agarose gel with the presence of two distinct bands depicting 18S and 28S 
rRNA indicating the quality of RNA isolation and absence of any degradation. In 
order to eliminate any possible DNA contamination, the RNA preparation was 
subjected to DNase digestion using Amplification Grade Deoxyribonuclease I 
(Sigma Aldrich, NSW, Australia) and immediately processed for cDNA synthesis.  
The reverse transcription reaction using random hexamer primers was performed 
using the Transcriptor First Strand cDNA Synthesis Kit (Roche, NSW, Australia) 
according to the manufacturer’s instructions. The cDNA obtained was used as 
template for conventional PCR and qrtPCRs. 
 
Koala cytokine sequence cloning and sequencing 
Primers for koala cytokine gene detection were designed based on alignment of 
homologous gene sequences from other species. A sequence alignment was carried 
out for the coding sequence of each gene from various species accessioned in 
Genbank, with Trichosurus vulpecula (Australian common brushtail possum) as the 
reference sequence for primer design. For IL10 primer design, brushtail possum, 
dog, cat, horse, pig, human, rat, rabbit and mouse IL10 sequences were used for 
alignment construction. Similarly, for TNFα primer design, brushtail possum, red 
kangaroo and wallaby TNFα sequences were used. The primers were designed along 
highly conserved regions to maximise chances of amplifying the corresponding gene 
in the koala (data not shown). 
 
Upon successful amplification, PCR product of the expected size was cloned into a 
plasmid using Promega pGEM-T Easy Vector Systems I. In order to validate the 
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sequences, a minimum of five clones were grown overnight at 37oC in LB medium 
(Luria-Bertani Medium) with ampicillin (100 µg/ ml) with intermittent shaking. 
DNA was extracted using the Purelink Quick Plasmid Miniprep Kit (Invitrogen, 
Victoria, Australia). Success of cloning was determined by digesting the plasmid 
DNA using Restriction Endonuclease EcoR I (Roche, Applied Science, Germany). A 
single digest with EcoR1 releases inserts cloned into the pGEM-T Easy Vector. The 
digested product was then run on a 1.5% agarose gel along with the uncut plasmid. 
The presence of a band of the expected size indicated successful insertion of the 
target sequence into the vector. The products were then sequenced at Australian 
Genome Research Facility using the AB 3730xl platform. 
 
Design and optimisation of koala cytokine quantitative SYBR Green I RT-PCR 
assays 
Koala TNFα and IL10 cytokine mRNAs identified as part of this study were used to 
design primers for the qrtPCR assay using Primer Express® Software v3.0 by 
Applied Biosystems targeting 180 bp and 72 bp regions, respectively. The sequences 
for each primer used in qrtPCR assays are summarised in Table 1. Furthermore, 
primers which would amplify a PCR product spanning over two postulated exons 
based on comparison of these locations in tammar wallaby or human sequences were 
designed in order to avoid any co-amplification of contaminating genomic DNA in 
the reaction mixture (Figure 1). 
 
The target cytokine genes were optimised into qrtPCR assays using SYBR Green I 
dye chemistry for gene quantification at the mRNA level. Assay efficiency was 
determined by constructing standard curves for the two cytokines using purified PCR 
 84 Chapter 3:  
product serial dilutions of known concentration at  102, 104, 106, 108 gene copy 
numbers. Conventional PCR with each gene-specific primer pair was used to prepare 
serially diluted qrtPCR standards (102, 104, 106 and 108). Approximately 100 µl of 
the amplified PCR product was run on a 1.5% agarose/ TBE gel to confirm 
successful amplification. Corresponding bands were excised from the gel and 
solubilised using the High Pure PCR Product Purification Kit (Roche, Applied 
Science, Germany) as per the manufacturer’s instructions. Purified PCR product was 
checked for quality and concentration using Nanodrop ND-1000 Spectrophotometer 
at absorbance of 260 and 280 nm wavelengths. The number of molecules of the 
product was calculated using Avagadro’s formula. 
 
All reactions were carried out on a Corbett Rotor Gene 6000 real time PCR machine 
at a final volume of 20 µl, with 1 unit of Fastart Taq Polymerase (Roche), 2 µl of 25 
mM MgCl2
 (Roche), 2 µl of 10 x buffer (Roche), 1 µl of 10 mm dNTPs (Roche), 3 
µl of 1/10000 SYBR Green and 0.6 µl each of 5 mM forward and reverse primers. 
After an initial incubation of 95oC for 10 mins, 40 cycles of 10 s at 95oC, 25 s at 
56oC and 15 s of 72oC were carried out for IL10 qrtPCR. For TNFα qrtPCR, after an 
initial incubation of 95oC for 10 mins, 40 cycles of 10 s at 95oC, 20 s at 54oC and 15 
s of 72oC were carried out. All samples were tested in triplicate. Reactions were 
carried out at a final volume of 20 µl. Mastermix with no cDNA was used as the no 
template control whereas water was used as the negative control. 
 
In order to facilitate comparison between animals and experiments and to normalise 
the variable amount of starting material used for each experiment, GAPDH, a house-
keeping gene, was chosen as reference gene for the qrtPCR assay. The koala 
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GAPDH gene was isolated using consensus primers designed from available 
GAPDH gene sequences. The real time GAPDH primers targeted a 70 bp region for 
which standards of known concentrations of 102, 104, 106 and 108 copy numbers 
were prepared as previously described. The reactions were carried out in 20 µl final 
volume. An initial incubation of 95oC for 10 mins was followed by 40 cycles of 
denaturation for 10 s at 95oC, 15 s annealing at 52oC and 20 s extension at 72oC for 
GAPDH qrtPCR assay. The target cytokine genes were normalised to GAPDH by 
the 2-ΔΔCT method, where ΔΔCT = (Ct of target - Ct of GAPDH) at any time point - 
(Ct of target - Ct of GAPDH) at time zero hour [25].  
 
 TNFα and IL10 mRNA production in koala PBMCs upon in vitro exposure to 
chlamydial antigens 
In order to determine TNFα and IL10 production levels in koalas upon exposure to 
chlamydial antigens, blood samples were collected from 10 koalas brought into 
Australia Zoo Wildlife Hospital. PBMCs were processed from the blood samples and 
cultured in the presence of UV inactivated C. pecorum. A 500µl stock of semi-
purified C. pecorum G [26] was UV inactivated as described by Rey-Ladino et al. 
[27] and further diluted 1/20 dilution in RPMI 1640 T cell media. The plasma 
samples from these animals were stored at -80oC for use in western blot analysis. 
Cells were then cultured in the presence of UV inactivated C. pecorum G at 1:1 ratio 
for durations of 12, 24 and 48 hours. Unstimulated cells were collected at the start of 
the experiment to calculate baseline data for qrtPCR assays. At the end of the 
stimulation periods, RNA extraction and cDNA synthesis was performed and TNFα, 
IL10 and GAPDH mRNA expression was determined using our koala specific 
qrtPCR assays, designed as part of this study. 
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C. pecorum species specific PCR screening and Western Blot analysis 
To determine the current and previous C. pecorum infection status of koalas 
analysed as a part of this study, swab samples (eyes, urogenital tract) and blood 
samples were collected from 10 koalas that presented to the Australian Wildlife 
Hospital for veterinary care (Table 2).   
 
The presence of C. pecorum DNA in koala swabs was determined using a previously 
described C. pecorum species-specific qPCR [28] targeting a 202 bp region of the 
16S rRNA region using primers 16Sf (5’ – AGTCGAACGGAATAATAATGGCT – 
3’) and 16Sr (5’ – CCAACAAGCTGATATCCCAC – 3’). Briefly, DNA was 
extracted from swab samples following vortexing and centrifugation and then used 
as a template in the qPCR. 25 µl PCR reactions were performed in duplicates with 3 
µl of extracted DNA template, 1 unit of Fastart Taq Polymerase (Roche), 2.5 µl of 
25 mM MgCl2
 (Roche), 2 µl of 10 x buffer (Roche), 0.6 µl of 10 mm dNTPs 
(Roche), 3 µl of 1/10000 SYBR Green and 0.6 µl each of 10 mM forward and 
reverse primers. Reactions were carried out in a Corbett Rotor Gene 6000 real time 
PCR machine with an initial denaturation at 95oC for 5 mins, followed by 94 oC for 
30 s, annealing at 57 oC for 15 s and extension at 72 oC for 25 s for 40 cycles. 
Standards with 108, 106, 104 and 102 of C. pecorum 16s rRNA genomic DNA copy 
numbers were used as calibrators for the assay. High resolution melt analysis was 
performed to confirm the C. pecorum specific PCR product with a melting 
temperature range between 82oC and 85oC. 
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Western blots were performed using recombinant C. pecorum His-tagged major 
outer membrane protein (MOMP) A, F and G antigens as described by Kollipara et 
al. [29] to detect the presence of C. pecorum MOMP-specific koala IgG antibodies in 
the koala plasma samples.  
 
Based on the results and the presence of overt signs of koala chlamydiosis, the 10 
koalas sampled as a part of this study were divided into three groups: Group I – 
koalas with current clinical signs of chlamydiosis; Group II – C. pecorum PCR 
and/or western blot positive koalas without overt signs of chlamydiosis; and Group 
III – PCR and/or western blot negative koalas with no overt signs of chlamydiosis. 
 
Statistics 
Graph-Pad Prism version 5 (Graph Pad Software, Lajolla, CA, USA) was used to 
perform statistical analyses. Unpaired t- test with the P value set at < 0.05 was used 
to analyse significance of TNFα and IL10 mRNA expression relative to GAPDH 
among the different groups of koalas analysed. 
 
RESULTS 
Koala cytokine mRNA sequence identification and analysis 
This is the first study to report the sequences of any koala cytokine. As the starting 
point for this study, consensus primers were designed against partial sequences for 
the TNFα gene from brushtail possum, red kangaroo and wallaby. Similarly, for 
IL10 primer design, brushtail possum, dog, cat, horse, pig, human, rat, rabbit and 
mouse IL10 sequences were used. Following successful PCR amplification and 
sequencing of the cloned PCR products, 958 bp of koala TNFα (GenBank accession 
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number – JX845580) and 479 bp of koala IL10 (GenBank accession number - 
JX845581) mRNA were identified (Figure 1a and 1b). BLAST analysis of available 
sequences and comparison of the TNFα sequence in the koala with sequences from 
other marsupials, mammals and avians, shows that, not surprisingly, the koala 
sequences are more similar to the red kangaroo (90.1%), tammar wallaby (88.7%), 
North American opossum (80.7%) and brushtail possum (84.4%) sequences than 
they are to the mammalian or avian TNFα sequences. A comparison of the koala 
IL10 sequence revealed a similar picture, with the highest homology observed with 
the marsupial species sequences available from, brushtail possum (91%) and North 
American opossum (83.9%), compared to the mammalian or avian species.  
 
The total length of TNFα mRNA in humans and tammar wallaby is 1669 bp 
(GenBank: NM_000594) and 1771 bp (GenBank: AY853666) respectively. The 
tammar wallaby TNFα gene consists of 4 exons and 3 introns. We cloned 958 bp of 
the koala TNFα nucleotide sequence which corresponds to the entire first, second 
and third exons of the sequence as well as approximately 65% of exon 4 (Figure 1a). 
This covers the entire 5’ untranslated region and the complete coding sequence for 
the protein [30].  An analysis of the koala TNFα amino acid sequence with reference 
to the human TNFα reveals several structural similarities (Figure 2a). The predicted 
transmembrane and intracytoplasmic regions show considerable homology [30] and 
the receptor binding sites are highly conserved as well [31]. 
  
The complete mRNA of brushtail possum IL10 is 1604 bp long (GenBank: 
AF026277) which has 91% similarity to the 479 bp of the cloned IL10 koala 
sequence. Of the five exon regions of the brushtail possum IL10 gene, the available 
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koala sequence spans exons 1, 2, 3, 4 and 5 (Figure 1b). The koala IL10 sequence 
cloned as part of this study lies within the coding sequence for the protein when 
compared to the brushtail possum IL10 coding sequence. The brushtail possum IL10 
coding sequence translates to a 175 amino acid protein, whereas the koala IL10 
sequence translates to a 159 amino acid sequence. An evaluation of the koala IL10 
amino acid sequence with reference to the human IL10 sequence reveals 
conservation of several key features. Four cysteine residues that form intramolecular 
disulphide bridges in human IL10 protein are conserved in the deduced koala IL10 
sequence (Figure 2b). Similarly, residues that are important for IL10 structural 
stabilisation [32] are also conserved across the two species (Figure 2b). 
 
The relationship of the koala TNFα and IL10 sequences with other marsupial and 
mammalian TNFα and IL10 sequences is illustrated in a phylogenetic tree (Figures 
3a and 3b). It shows that the marsupial, mammalian and avian TNFα and IL10 
sequences have evolved along different lines, with the koala sequences forming a 
distinct clade with other marsupial sequences, away from placental mammals and 
birds. 
 
Development of koala cytokine qrtPCR assays 
qrtPCR assays were developed using koala TNFα, IL10 and GAPDH sequences to 
measure their expression in koala peripheral blood samples. The primers for all three 
genes were designed such that the amplicons would span over at least one intron-
exon junction, thereby eliminating any chances of amplifying contaminant DNA left 
in the sample.  
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R2 values for all assays was found to be 0.99. The CT value of the standards used was 
found to be similar in consecutive runs, thereby confirming the reproducibility of the 
assay. Moreover, agarose gel visualisation of representative replicates from RT-PCR 
reactions revealed appropriately-sized bands. Efficiency of the reaction was 
calculated as 10(-1/slope). All three assays achieved greater than 90% efficiency. These 
values illustrate that the RT-PCR assay for the TNFα, IL10 and GAPDH gene are 
optimised and can be used for quantification of these genes in an unknown sample. 
 
TNFα and IL10 expression in koala PBMCs stimulated with UV- inactivated C. 
pecorum  
To provide preliminary data on the koala TNFα and IL10 response to chlamydial 
infection, blood samples were collected from 10 koalas presenting to the Australia 
Zoo Wildlife Hospital for veterinary care. Four koalas (Group I) included in this 
analysis presented with signs consistent with active chlamydial infection (i.e. 
conjunctivitis and/or cystitis) whereas the remaining six animals were brought into 
the hospital for conditions other than chlamydial infection (Table 2). Ocular and 
urogenital swabs were collected from all animals and screened for the presence of C. 
pecorum DNA. Of the Group I animals, two animals were found to be qPCR positive 
at one or more sites, however, the remaining two animals were PCR negative at the 
time of testing. All other animals were qPCR negative for C. pecorum DNA. To 
evaluate previous exposure to a C. pecorum infection, the presence of koala-C. 
pecorum specific IgG antibodies was determined for all animals by Western blot 
using a panel of recombinant C. pecorum MOMPs. All four Group I animals were 
found to be positive for C. pecorum MOMP-specific IgG (data not shown). Of the 
remaining animals, three animals without over signs of chlamydiosis were also found 
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to be Western blot positive (Group II) while the rest were Western blot negative 
(Group III).  
 
PBMCs isolated from all koalas were stimulated with UV-inactivated semi-purified 
C. pecorum elementary bodies for 12, 24 and 48 hours and TNFα and IL0 mRNA 
expression was measured using our koala specific qrtPCR assays, developed as part 
of this study. On stimulation with UV inactivated C. pecorum, significantly higher 
mRNA expression levels (P < 0.05) for IL10 was observed in PBMCs obtained from 
Group I animals compared to animals in Groups II and III (Figure 4). However, for 
TNFα mRNA expression a significant difference (P < 0.05) in expression levels was 
observed only between Group I and II animals. With one as the baseline for 
unstimulated PBMCs at 0 hour, a 10 to 50 fold increase was observed in TNFα 
mRNA expression levels relative to GAPDH at the 48 hours post-stimulation 
timepoint in Group I animals. Similarly, a 100 to 350 fold increase in IL10 mRNA 
relative expression (Figure 4) could be observed in the same animals. On average, 
IL10 mRNA expression levels were observed to be higher (P < 0.05) than TNFα 
mRNA expression levels in Group I animals (with current chlamydial disease). In 
either Group II or Group III animals, no statistically significant difference could be 
observed between koala TNFα and IL10 mRNA expression, except for the 
expression (P< 0.05) of IL10 mRNA at 48 hour time point stimulation which was 
caused by a high IL10 mRNA expression by an individual animal included in Group 
III. 
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DISCUSSION  
Very little is known about the immune system of the koala, confounding efforts to 
understand and develop strategies to control chlamydial infections in this host. Early 
studies suggested that the koala is an ‘immunologically lazy’ animal, as delayed 
humoral immune responses were observed, when compared to placental mammals 
[33]. However, these reports have not been supported by data from our recent studies 
evaluating the efficacy of a prototype koala chlamydial vaccine [34, 29] as 
significant humoral and CMI responses to chlamydial antigens, with similar kinetics, 
magnitude and duration as seen in other species can be readily detected. A limitation 
of these studies, however, was an inability to profile the expression of cytokine 
genes associated with the CMI response since no reagents were available for use in 
these studies. Hence, the main aim of this study to develop the first reagents to 
measure cytokine expression in the koala and to provide preliminary data on their 
response to C. pecorum infection.  
 
Before this study, no information was available regarding any koala cytokine gene. 
Hence, as a first step, nucleotide sequences of the TNFα and IL10 cytokine genes 
were determined and used to design qrtPCR based assays. The expression of these 
cytokines was then compared to the housekeeping gene, GAPDH, in order to correct 
the variation in input RNA in different samples. The efficiency of the qrtPCR assays 
was shown to be reproducible over subsequent experiments, hence implying the 
reproducibility of the assays. 
 
The cloned partial sequence of the koala TNFα nucleotide sequence has more than 
80% homology to other marsupial TNFα sequences. This level of variability is 
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similar to what is observed among the TNFα sequences of placental mammals 
(>80%; data not shown). Similar to koala TNFα, the IL10 nucleotide sequence also 
has more than 80% homology to the two available marsupials IL10 sequences which 
is comparable to the extent of similarity between the IL10 sequences of the placental 
mammals. It is this level of conservation at the nucleic acid level of the TNFα and 
IL10 cytokines among different species, as well as within the marsupials that has 
enabled their successful cloning in the koala based on the principal of consensus 
primer design. Hence, this methodology can be employed for the cloning of other 
koala cytokines for which corresponding marsupial sequences are available.  
  
In a preliminary study to evaluate the role of these cytokines in koala chlamydial 
infections and disease, TNFα and IL10 responses of koala PBMCs, isolated from 
three cohorts of koalas was measured (Figure 4). Although high levels of variability 
was observed within each group, there was a significantly high expression (P < 0.05) 
of TNFα and IL10 mRNA in animals with current chlamydial disease when 
compared to the remaining animals in the study. Elevated TNFα levels have been 
observed and associated with conditions such as atherosclerosis and coronary heart 
disease resulting from C. pneumoniae infection [35, 36]. IL10, on the other hand, is 
an anti-inflammatory cytokine known to play a critical role in chronic infections 
caused by intra-cellular organisms. During chlamydial infection, high IL10 
production has been associated with pathogenesis [37, 38] in a mouse model of C. 
trachomatis infection. Moreover, elevated levels of IL10 have also been observed in 
women with disease caused by C. trachomatis [39, 40]. The observation of high 
levels of IL10 gene activation in the diseased koalas from Group I may provide the 
first glimpse at understanding the differences in immune response between 
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asymptomatically infected koalas and koalas with chlamydial disease presentations. 
In the studies in other hosts, an increase in IL10 production corresponded with a 
decrease in interferon-gamma (IFNγ) production, which is the principle Th1 
cytokine that provides protection against chlamydial infection [41]. IL10 is known to 
suppress Th1 cytokine response by inhibiting TNFα and IFNγ, the latter two having 
a synergistic effect on each other [23]. Even though a 300 fold increase in IL10 
mRNA expression compared to a 60 fold increase in TNFα expression in koalas with 
chlamydial disease analysed in this study may be an indication of a similar role 
played by IL10 expression in koalas as well, a conclusive link can be established 
only after analysing the IFNγ expression in these animals. No reagents are currently 
available to measure the latter cytokine, however. 
 
Several factors will need to be considered in future investigations of the koala 
immune response to chlamydial infection. These include the site of the current 
chlamydial infection, the genetic diversity of the infected C. pecorum strains [26, 29] 
as well as the age and gender of the animal, beyond the fact that these animals are 
genetically out-bred. The genetic diversity of C. pecorum MOMP, for instance, may 
partially explain why several animals in Group III produced low levels of TNFα and 
IL10 expression, respectively, despite being negative by our MOMP-based western 
blot assays. Other host factors that will also need to be considered include 
polymorphisms in the IL10 promoter gene and the TNFα, coding sequence which 
has been shown to affect human immune responses to C. trachomatis infection [42, 
43]. We did not examine the presence of genetic variation between the IL10 and 
TNFα sequences between different koalas but this should be a focus for further 
investigations. The current study analysed in vitro TNFα and IL10 production by 
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koala PBMCs on exposure to UV-inactivated C. pecorum. However, it is known that 
chlamydial disease is a manifestation of localised infection and cytokines have a 
localised mechanism of action. Hence, along with the analysis of more cytokines to 
better understand the immune response of the koala to chlamydial infection, 
examining local cytokine production at the site of infection will provide valuable 
information regarding chlamydial disease in the koala.  
 
CONCLUSION 
The identification of the first cytokine sequences from the koala and the 
development of much-needed immunological reagents in this study have provided 
critical tools and much-needed baseline data on the koala immune system to begin to 
allow us to elucidate the role of the immune response to infections by this highly 
pathogenic bacterial infection. Broadening our understanding of the koala immune 
system is significant due to the ongoing and rapid declines of this native marsupial 
species across various parts of Australia. Direct and rapid interventions via 
vaccination of wild koalas is likely required to stabilise declining koala populations 
from disease threats and these assays, along with the identification of additional 
koala cytokines, will be critical in evaluating the efficacy of these strategies.  
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Table 1. qrtPCR primers for TNFα, IL10 and GAPDH genes. 
 
 
 
 
 
 
Table 2. Clinical presentation and C. pecorum infection status for animals 
analysed as part of this study 
 
Name Clinical Presentation C. pecorum species 
specific qPCR 
result 
C. pecorum MOMP 
Western Blot 
                                                           Group I 
Ben Cystitis Positive Positive 
Vicar’s Wife Cystitis Positive Positive 
Justine Conjunctivitis NEGATIVE Positive 
Khaleesi Cystitis NEGATIVE Positive 
                                                                Group II 
Ros Dog attack NEGATIVE Positive 
Mickey Vehicle hit NEGATIVE Positive 
Ally Gut disease NEGATIVE Positive 
                                                               Group III 
Scrubby Vehicle hit NEGATIVE NEGATIVE 
Callie Vehicle hit NEGATIVE NEGATIVE 
Atticus Healthy NEGATIVE NEGATIVE 
 
 
 
 
 
 
Gene  Forward Primer  5’ - 3’ Reverse Primer 5’ – 3’ Target 
TNF α GAGACGTAGAGCTAGCAG TGCCAAGAAAATCTGTGGAC 180 bp 
IL 10 TGGGCTCTTTAGGCGAGAAG CAGGGCAGGAATCTGTGACA 72 bp 
GAPDH GGACTCATGACCACAGT CCATCACGCCACAGC 70bp 
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Figure 1. The exon distribution and primer position of koala TNFα (a), IL10 (b) and 
GAPDH (c) genes when in alignment with other marsupial and human sequences of 
the corresponding genes. The forward and reverse primer sequences used in the RT-
PCR assays are highlighted in green and red, respectively. The PCR product has 
been designed such that it spans over an intron-exon junction. 
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Figure 2. Amino acid sequence alignment of koala, brushtail possum and human 
TNFα sequences. (a) Koala TNFα sequence characterisation is done with reference 
to the human TNFα sequence. Presequence comprising of 76 amino acids and the 
secreted form of 156 amino acids is indicated by the horizontal red and green lines 
respectively. The hydrophobic transmembrane region and the intracytoplasmic 
region are marked out in red and green boxes respectively [30]. Asterisks indicate 
the receptor binding sites of the protein [31]. (b) Koala IL10 sequence 
characterisation is done with reference to the human IL10 sequence. Cysteine 
residues which form intramolecular disulphide bonds in human IL10 are marked in 
red boxes. Residues important for structural stabilisation are marked in green boxes. 
The six α-helices of the IL10 monomer are depicted by dotted blue lines [32]. 
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Figure 3. Phylogenetic tree of (a) TNFα and (b) IL10 nucleotide sequence 
constructed using Geneious Pro 5.6.5 using Jukes Cantor, UPGMA tree build 
method with 1000 bootstrap repeat value.  
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Figure 4. TNFα and IL10 gene expression in koala PBMCs stimulated with UV 
inactivated C. pecorum in Group I, II and III animals. Samples were collected at 0, 
12, 24 and 48 hours. Results are expressed as fold increase compared to GAPDH. 
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Abstract 
Interferon gamma (IFNγ) is a key Th1 cytokine, with a principal role in the immune 
response against intracellular organisms such as Chlamydia. Along with being 
responsible for significant morbidity in human populations, Chlamydia is also 
responsible for wide spread infection and disease in many animal hosts, with reports 
that many Australian koala subpopulations are endemically infected. An 
understanding of the role played by IFNγ in koala chlamydial diseases is important 
for the establishment of better prophylactic and therapeutic approaches against 
chlamydial infection in this host. A limited number of IFNγ sequences have been 
published from marsupials and no immune reagents to measure expression have been 
developed. Through preliminary analysis of the koala transcriptome, we have 
identified the full coding sequence of the koala IFNγ gene. Transcripts were 
identified in spleen and lymph node tissue samples. Phylogenetic analysis 
demonstrated that koala IFNγ is closely related to other marsupial IFNγ sequences 
and more distantly related to eutherian mammals. To begin to characterise the role of 
this important cytokine in the koala's response to chlamydial infection, we developed 
a quantitative real time PCR assay and applied it to a small cohort of koalas with and 
without active chlamydial disease, revealing significant differences in expression 
patterns between the groups. Description of the IFNγ sequence from the koala will 
not only assist in understanding this species' response to its most important pathogen 
but will also provide further insight into the evolution of the marsupial immune 
system. 
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Highlights 
 First description of the IFNγ sequence from an Australian marsupial 
 Sequence analysis reveals around 70% similarity to other marsupial IFNγ 
sequence 
 Koalas with current chlamydial disease displayed higher IFNγ gene 
expression compared to koalas with no disease. 
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Introduction 
The koala (Phascolarctos cinereus) occupies a unique status in Australian culture. 
Despite continued efforts by a variety of groups to conserve this species, wild koala 
numbers continue to decline, prompting the Australian Government to include the 
koalas of Queensland, New South Wales and Australian Capital Territory in the 
threatened species list (Koala species listing, 2012). Among the many factors that 
contribute to the decline of koala populations across different regions of Australia, 
habitat destruction is reported to have the most wide reaching effects (Melzer et al., 
2000). In order to stabilise these declining populations, however, modelling has 
shown that a 50% reduction in the incidence of disease would likely have the most 
success (Rhodes et al., 2011). The main aetiological agent responsible for morbidity 
in this marsupial species is Chlamydia pecorum, with a reported prevalence rate as 
high as 72–100% in some populations (Polkinghorne et al., 2013). Common 
manifestations of C. pecorum infection in koalas are cystitis, proliferative 
conjunctivitis and chronic, fibrotic disease of the urogenital tract leading to infertility 
and death (Polkinghorne et al., 2013). In attempting to understand chlamydial 
disease pathogenesis, we have previously shown that C. pecorum infectious load is 
semi-independent of chlamydial disease chronicity in the koala (Wan et al., 2011). 
Many koalas with high infectious loads display either no effects of infection or 
active, proliferative disease, while koalas with low infectious loads often suffer 
severe, chronic disease manifestations. The latter observation is consistent with 
studies of other Chlamydia-infected host species where, in the absence of high 
infectious loads of Chlamydia, cross-reactivity of the host response to infection has 
also been implicated in disease pathogenesis (Darville and Hiltke, 2010). 
  
 113 
 
The ability to accurately measure the host immune response to chlamydial infection 
has been central to understanding the relationship between infection and disease. In 
this regard, in non-koala hosts, it has been shown that the activity of a key cytokine, 
interferon gamma (IFNγ), is required for the resolution and control of chlamydial 
infections (Loomis and Starnbach, 2002). IFNγ is a pleiotropic dimeric pro-
inflammatory cytokine secreted by T cells and Natural Killer (NK) cells (Farrar and 
Schreiber, 1993). This cytokine influences both the innate and cell-mediated immune 
response, playing important roles not only in the activation of pathways to recognise 
and clear intracellular pathogens (Rottenberg et al., 2002)and tumours (Shankaran et 
al., 2001) but also in (i) immunoglobulin class switching, genesis of T-helper 1 (Th1) 
cells (Farrar and Schreiber, 1993); (ii) enhanced major histocompatibility class 2 
(MHC-II) expression on mononuclear phagocytes and dendritic cells (Billiau and 
Matthys, 2009) and; (iii) differentiation of monocytes to macrophages (Delneste et 
al., 2003). Reflecting these important roles, it is not surprising to find that this gene 
has a wide distribution across most terrestrial and marine vertebrate lineages with a 
suspected evolutionary origin that dates back greater than 450 Ma ago (Savan et al., 
2009). It is interesting to note that in spite of its role in immune response to 
pathogens and the low sequence similarity observed among the major lineages of 
subphylum vertebrate, evolutionary conservation of the core structural features 
important in the biological function of the molecule has been identified (Savan et al., 
2009). Our efforts to understand the koala immune response to chlamydial infection, 
including the IFNγ response, are restricted due to the lack of sequence information 
(and assays) for key koala cytokines. While we have been able to overcome some of 
these challenges using conventional PCR and degenerate primers based on 
mammalian orthologous (Mathew et al., 2013), this approach is challenging due to a 
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low level of sequence conservation for IFNγ, and attempts to use this approach in 
other Australian marsupials have experienced mixed success (Harrison and Wedlock, 
2000). The emergence of high-throughput methodologies to sequence coding genes 
from non-model organisms has revolutionised our ability to identify immune genes 
of interest from organisms with no previous genomic resources (Wong et al., 2006) 
and has allowed us to rapidly acquire and analyse the complete immune gene 
repertoires of an increasing number of non-model hosts (Hoffman et al., 2013; 
Papenfuss et al., 2012). 
 
As a part of our ongoing efforts to characterise the transcriptome of the koala 
(unpublished data), we report the molecular analysis of a marsupial IFNγ. In an 
effort to understand the role of this cytokine in the koala host response to chlamydial 
disease, we designed koala specific quantitative real time (qrtPCR) assay and 
performed preliminary analysis on the expression of this cytokine gene in healthy 
koalas as well as in animals with overt chlamydial disease. This analysis not only 
provides insight into the function of this gene in the koala but sheds light on the 
evolution of the Th1 response in marsupials. 
 
2. Materials and Methods 
2.1. Ethics statement 
Queensland University of Technology Animal Ethics Committee (Approval No. 
0700000845) approved the collection and subsequent analysis of the koala blood 
samples. Blood samples were collected by qualified veterinarians from koalas 
admitted to the Australia Zoo Wildlife Hospital, Beerwah, Queensland, Australia. 
Blood was collected from animals anesthetised for other clinical procedures. 
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2.2. Transcriptomic analysis of koala tissues 
Total RNA was extracted from four immune related tissues; liver, lymph node, 
spleen and bonemarrow, using a Trizol/Chloroform extraction. Paired-end 
sequencing of polyA enriched samples was performed on an Illumina HiSeq 2000, at 
Beijing Genomics Institute. For each tissue type, raw sequencing data was de novo 
assembled using CLC Genomics workbench version 6.0.2 using the following 
settings: kmer 24: mismatch cost 2; limit 8; insertion cost 3; deletion cost 3; length 
fraction 0.8; similarity 0.8; minimum distance 150; maximum distance 250. 
Assembled contigs for the different tissue libraries were used as BLASTx queries 
against the IFNγ protein sequence from Monodelphis domestica with a stringency of 
greater than 1 × 10−5. Contigs that met these stringency requirements were used for 
downstream bioinformatic analysis. 
 
2.3. Bioinformatics analysis of koala IFNγ sequence 
Multiple sequence alignments were carried out using the Geneious alignment 
program in the Geneious Pro 5.6.5 software at a cost matrix of 65% similarity and 
GeneDoc version 2.7.000 software. Phylogenetic trees were constructed using Jukes 
Cantor, neighbour joining tree build method in Geneious Pro 5.6.5. IFNγ sequences 
for alignment and phylogenetic tree construction were obtained from GenBank and 
Ensembl: armadillo (DQ094083), buffalo (EU277737), camel (AB107657), cat 
(X86972), dog (FJ194478), elephant (EU000432), platypus (XM_001511108), 
human (BC070256), monkey (NM_001032905), chicken (AY501004), pigeon 
(DQ479967), common carp (AM168524), goldfish (EU909368), opossum (Wong et 
al., 2006), tammar wallaby (ENSMEUT00000007026) and Tasmanian devil 
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(ENSSHAT00000017850). The koala IFNγ was uploaded to GenBank with 
accession number KC894757. 
 
2.4. Koala sample collection 
PBMCs were harvested from 10 koala blood samples for use in this study. 5–6 ml of 
blood was collected in 6 ml EDTA blood tubes from koalas brought into the hospital. 
Bloods were stored at 4 °C until further processing on the same day. Swabs for 
Chlamydia analysis were collected from the conjunctiva of the left eye, right eye, 
urogenital sinus (females) and urethra (males) using aluminium shafted cotton tipped 
swabs (Copan, Interpath Services, Melbourne). Current and previous C.  pecorum 
infection status of these animals was determined using a previously described 
16SrRNA C. pecorum species-specific qrtPCR assays (Wan et al., 2011) and western 
blots using C. pecorum His-tagged major outer membrane protein (MOMP) A, F and 
G (Kollipara et al., 2012). 
 
2.5. IFNγ qrtPCR assay design and optimisation 
The koala IFNγ mRNA sequence obtained from the lymph node transcriptome was 
used to design primers for IFNγ qrtPCR assay. Primers were designed to target a 167 
bp product which spanned across exon 1 and exon 3 in order to avoid co-
amplification of contaminating genomic DNA. The primers used for the IFNγ 
qrtPCR assay were as follows: F (5′-AGCTACCTCTTAGCATCC-3′) and R (5′-
TCCTCTTTCCAACGATCC-3′). This 167 bp koala sequence was cloned in to a 
plasmid using the Promega pGEM-T Easy Vector Systems I as described in Mathew 
et al. (2013). The successfully cloned PCR product was then sequenced at the 
Australian Genome Research Facility using the AB 3730xl platform to confirm 
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specificity of the primers used. SYBR Green I based dye chemistry was used to 
optimise the IFNγ qrtPCR assay. Assay efficiency was determined using a standard 
curve constructed using serial dilutions of the 167 bp PCR product as previously 
described (Mathew et al., 2013). All reactions were carried out on a Corbett Rotor 
Gene 6000 real time PCR machine at a final volume of 25 μl, with 1.3 units of 
FastStart Taq Polymerase (Roche), 2.5 μl of 25 mM MgCl2 (Roche), 2.5 μl of 10× 
buffer (Roche), 2.5 μl of 10 mm dNTPs (Roche), 3 μl of 1/10,000 SYBR Green and 
1 μl each of 10 mM forward and reverse primers. After an initial incubation of 95 °C 
for 5 min, 35 cycles of 25 s at 95 °C, 30 s at 52 °C and 35 s of 72 °C were carried out 
for each IFNγ qrtPCR. All samples were tested in duplicate. A mastermix with no 
cDNA was used as the no template control and water was used as the negative 
control. A glyceraldehyde 3-phosphate dehydrogenase (GAPDH) qrtPCR assay 
described in Mathew et al. (2013) was used as a reference gene. The IFNγ cytokine 
gene was normalised to GAPDH by the 2−ΔΔCT method, where ΔΔCT = (Ct of 
target − Ct of GAPDH) at any time point − (Ct of target − Ct of GAPDH) at time 
zero hour (Livak and Schmittgen, 2001). 2.6. Koala lymphocyte stimulation with 
chlamydial antigens, RNA extraction and reverse transcription to measure IFNγ 
production upon in vitro exposure to chlamydial antigens In order to measure IFNγ 
production levels in koalas upon exposure to chlamydial antigens, PBMCs were 
harvested from 10 koala blood samples, diluted to a concentration of 2 × 106 
cells/ml in RPMI 1640 T cell media and stimulated with 1/20 dilution of UV 
inactivated C. pecorum G as described in Mathew et al. (2013).500 μl of 
unstimulated cells at a concentration of 2 × 106 cells/ml was used for RNA 
extraction to serve as a baseline for the IFNγ gene transcription in stimulated cells. 
At 12, 24 and 48 h post-stimulation, cells were harvested for RNA extraction and 
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subsequent reverse transcription as described previously (Mathew et al., 2013). 
mRNA expression of IFNγ and GAPDH was determined using our optimised koala 
specific IFNγ and GAPDH qrtPCR assays. 
 
2.7. Statistics 
Graph-Pad Prism version 5 (Graph Pad Software, Lajolla, CA, USA) was used to 
perform statistical analyses. Unpaired t-test with the P value set at b0.05was used to 
analyse significance of IFNγ expression relative to GAPDH among the different 
groups of koalas analysed. 
 
3. Results 
3.1. Transcriptomic identification of koala IFNγ 
Using the assembled contigs for each library, we identified two contigs that matched 
the IFNγ protein sequence from M. domestica with a stringency of e<10−60. One 
contig was detected in the lymph node library and corresponded to a full length 
coding sequence of 711 bp, while the second contig was identified in the spleen 
library with only a partial coding sequence of 493 bp.  
 
3.2. Koala IFNγ sequence analysis 
In this study, we describe the koala IFNγ coding sequence (Genbank Accession 
#KC894757). The koala IFNγ cDNA contains a 495 bp coding region that encodes a 
protein of 165 amino acids. The 5′ UTR region is 127 bp long whereas the 3′ UTR is 
89 bp long. A polyadenylation site (AAAATA) is present at the 3′ end. In the 
absence of structural data for any other marsupial IFNγ gene, an analysis of the koala 
IFNγ amino acid sequence with respect to the human IFNγ sequence was performed 
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(Fig. 1). It reveals sequence conservation in regions of functional importance in this 
marsupial species in spite of the low comparative sequence identities — the overall 
amino acid similarity ranging between 14 and 84% amongst the piscine, avian, 
mammalian and marsupial species analysed. The koala IFNγ sequence has a dN/dS 
ratio of 0.96, 0.86 and 0.26 against the opossum, tammar wallaby and Tasmanian 
devil sequences, suggesting that it is under neutral to purifying selection pressure. 
Conservation of the signal peptide (19 amino acids) and two potential N-linked 
glycosylation sites can be observed within the coding region (Devos et al., 1982). As 
is observed in other mammalian and piscine species, the koala also possesses the 
IFNγ signature sequence ([I/V]-Q-X-[K/Q]-A-X2-E-[L/F]-X2-[I/V]) at the C-
terminal end of the protein (Fig. 1). Similarly, the koala IFNγ sequence possesses the 
conserved sequence (KRKR) for nuclear localisation site at the C terminal end like 
other mammalian IFNγ sequences (Subramaniam et al., 1999). Furthermore, three 
AU-rich regions (AUUUA) involved in the post translational control of IFNγ gene 
expression are present in the koala IFNγ gene (Khabar, 2005).  
 
To understand the phylogenetic relationships between the koala IFNγ gene sequence 
and other representative sequences from the major lineages of subphylum vertebrata, 
IFNγ sequences from a range of hosts were subjected to multiple sequence alignment 
and subsequent phylogenetic tree construction. Based on the sequence alignment 
constructed using the coding sequence of IFNγ gene of other species (Fig. 2), the 
koala sequence has 77–89.5% sequence identity to the marsupials, but only 60–
63%sequence similarity to other mammalian IFNγ sequences, 42–47% similarity to 
avian species, 36–37% with the piscine species and 59.7% to the platypus. An 
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expanded analysis for sequence similarity of the koala IFNγ gene to other animal 
species is given in Table 1. 
 
Construction of the phylogenetic tree for the IFNγ sequence of diverse species (Fig. 
3) revealed the presence of distinct clades. With chicken and pigeon IFNγ sequences 
used as the root of the tree, the koala IFNγ sequence clustered with the other 
marsupial species and formed a sister group to the eutherians. The piscine and 
monotreme species grouped away from the eutherian and marsupial species. 
 
3.3. Development of koala IFNγ qrtPCR assay 
qrtPCR assays based on SYBR Green I dye based chemistry were developed to 
measure IFNγ expression in koala peripheral blood samples. The primers were 
designed to span at least one intron–exon junction to eliminate the chances of 
genomic DNA amplification in the PCR reaction (Fig. 2). Assay optimisation was 
measured based on the R2 value, the efficiency of the reaction and the reproducibility 
of the assay. An R2 value of 0.99 was observed in all the IFNγ qrtPCR runs. 
Efficiency of the reaction as calculated by 10(−1/slope) was greater than 90%. The 
reaction had a detection limit as low as 5–10 copy numbers of the target gene (data 
not shown). From these values it can be deduced that the IFNγ qrtPCR assay is 
sufficiently optimised and can be used for the detection of the gene in an unknown 
sample. 
 
3.4. IFNγ expression in koala PBMCs stimulated with UV-inactivated C. pecorum 
As part of a preliminary study to evaluate the Th1 response of koalas infected with 
the major pathogen, C. pecorum, we applied our IFNγ qrtPCR assays to a small 
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cohort of previously screened koalas brought to the Australian Zoo Wildlife Hospital 
for veterinary care (Mathew et al., 2013). Briefly, the 10 koalas were divided into 
three groups: Group I (n = 4) — koalas with current clinical signs of chlamydiosis; 
Group II (n = 3) — koalas that were negative by C. pecorum PCR but positive by 
western blot for anti-MOMP IgG but without overt signs of chlamydiosis; and Group 
III (n = 3) — koalas that were negative by PCR, negative by western blot and not 
showing any overt signs of chlamydiosis. PBMCs extracted from the 10 koalas were 
used to measure the IFNγ gene expression levels upon exposure to C. pecorum 
antigens. For this purpose, the PBMCs were stimulated with UV inactivated C. 
pecorum G for 12, 24 and 48 h, as previously described (Mathew et al., 2013). The 
IFNγ and GAPDH qrtPCR assays developed as part of this study were used to 
quantify the IFNγ gene expression levels. Following stimulation with UV inactivated 
C. pecorum G, the PBMCs from animals in Group I had significantly higher (P < 
0.05) IFNγ mRNA expression levels when compared to the other two groups of 
animals. With one as the base line for unstimulated PBMCs at 0 h, a 100–250 fold 
increase in IFNγ expression levels relative to GAPDH was observed in Group I 
animals over a period of 48 h (Fig. 4). A peak in IFNγ expression was observed 
either at 12 or 24 h post-stimulation for individual animals. Interestingly, animals in 
Group I which were PCR negative by C. pecorum 16S rRNA PCR had IFNγ 
expression levels comparable to that of the PCR negative animals in other groups. 
This is consistent with our previous observations for TNFα and IL10 gene 
expression in the same cohort of koalas (Mathew et al., 2013). Of the three animals 
included in Group II, one animal displayed a seven fold increase in IFNγ expression 
at 12 h post stimulation compared to the almost nil response by the remaining two 
animals. For the animals in Group III, the IFNγ expression levels ranged from 0.6 to 
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3 fold increase over the course of antigenic stimulation. All animals included in this 
study had detectable levels of IFNγ expression at any one of the time points tested 
which is similar to observations made in other hosts (Gupta et al., 2009). No 
statistically significant difference was observed between the IFNγ expression levels 
of animals in Group II and III. 
 
4. Discussion 
In the current study, we provide the first molecular and immunological analyses of 
IFNγ from a member of the order Diprodontia, a large and diverse group of 
Australian marsupials. IFNγ is a key marker and the principal effector of the Th1 
immune response (Mosmann and Coffman, 1989) and is also produced by CD8 cells 
(Sad et al., 1995) and natural killer (NK) cells (Perussia, 1991). The molecular 
analysis presented in this study, not only provides insight into the immune response 
of the koala to its major bacterial pathogens but will also serve as the basis for 
expansion of studies examining Th1 and related innate and adaptive immune 
responses of other marsupials. Eutherian IFNγ gene sequences share very low 
sequence similarity with other non-eutherian vertebrate species (Savan et al., 2009) 
and our data showed even lower sequence conservation between marsupial and 
eutherian mammals. Consequently, it is not surprising that isolating the koala IFNγ 
sequence using primers designed from homologous sequences has been difficult. 
This is not a new problem in the field of marsupial immunology (Harrison and 
Wedlock, 2000; Zelus et al., 2000) and has limited attempts to develop marsupial 
specific immune reagents. The lack of species-specific reagents, in turn, has 
potentially influenced the interpretations of previous marsupial immune response 
studies (Wilkinson et al., 1992). Our ongoing work to sequence the complete coding 
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sequences of the koala (unpublished), however, has allowed us to overcome the 
limitations of conventional methodologies, leading to the identification of the koala 
IFNγ coding sequence. This result is very promising and bodes well for efforts to 
reveal the complete immune gene repertoire of the koala as well as other related non-
model marsupial hosts for which genomic resources are currently lacking.  
 
Being an immune gene that is subject to high selection pressure, low interspecies 
sequence conservation is commonly observed for IFNγ amongst different 
vertebrates. However, conservation of certain key functional motifs has been 
observed even among divergent species such as the fish, birds and the mammals 
(Savan et al., 2009). An analysis of the koala sequence with respect to other known 
IFNγ sequences reveals a similar scenario. The koala IFNγ nucleotide sequence 
shares maximum homology (89.5%) with the tammar wallaby IFNγ sequence; the 
least identity (36–37%) is observed with the farthest in the evolutionary lineage 
analysed, the piscine species. Despite the immune pressure to evolve rapidly and low 
sequence identity observed, it is interesting to find the conservation of functionally 
important IFNγ sequence motifs such as the signature sequence and the nuclear 
localization site in this marsupial species. This suggests a similar biological function 
for IFNγ in the koala as has been observed for the other vertebrate species. A 
phylogenetic analysis of IFNγ sequences revealed the clustering together of the 
marsupial species, with the eutherian species as the sister group. While the IFNγ 
gene appears to evolve rapidly across lineages, the dN/dS ratio of koala against other 
marsupials indicates that it has a substitution pattern consistent with neutral to 
stabilising evolution.  
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In small animal models, IFNγ is the principle Th1 cytokine secreted in response to 
chlamydial infection and has not only been associated with protective immunity to 
the host but also with immunopathology (Loomis and Starnbach, 2002; Yang, 2003). 
In humans, the role of this cytokine is less clear with recent evidence suggesting that 
Th2 response is more important for immunity and protection from associated 
pathology (Miguel et al., 2013). Nonetheless, measurement and characterisation of 
IFNγ are essential if we are to fully understand the koala's immune response to 
chlamydial infection and the disease pathogenesis process. As a preliminary study to 
generate baseline data regarding IFNγ gene expression in the koala against 
chlamydial infection, we quantified the levels of IFNγ expression in RNA samples 
extracted from the PBMCs of a small cohort of koalas, that we had previously 
characterised in terms of the (i) presence or absence of chlamydial disease and (ii) 
the current or previous C. pecorum infection status, as determined by C. pecorum 
specific qrtPCRs and western blotting of sera, and, (iii) the expression of other 
cytokines (tumour necrosis factor alpha, TNFα; interleukin-10; IL-10), newly 
identified using conventional PCR and sequencing approaches (Mathew et al., 2013). 
For the latter study, koalas were stimulated with UV inactivated C. pecorum G for 
12, 24 and 48 h, since it is known that IFNγ expression peaks 12–24 h after T cell 
stimulation (Farrar and Schreiber, 1993).At these time points, peak expression was 
most commonly observed at the 24 hour time point. IFNγ qrtPCR developed as part 
of this study was used to quantitate IFNγ gene expression relative to GAPDH. All 
the animals in the three groups examined, displayed a high level of variability across 
the time points for IFNγ gene expression (Fig. 4). Not surprisingly, the animals with 
detectable current manifestations of chlamydial disease had significantly higher 
IFNγ gene expression (P < 0.05) when compared to the other animals in the study.  
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Variable IFNγ expression levels were observed among animals in Group II. This 
wide difference could be related to the variable disease history of individual animals 
each having different points of infection and resolution of the disease leading to 
different IFNγ responses. However, unlike studies in animal models such as the 
mouse or guinea pig, it may be difficult to establish the dichotomy of T cell response 
in a naturally infected host such as the koala which is an out bred animal. In the 
absence of a longitudinal study, similar observations have been made in human 
studies where elevated levels of IFNγ and IL10, a pair of antagonistic cytokines, 
have been observed in cases of ocular (Burton et al., 2004; Faal et al., 2005) and 
genital disease (Reddy et al., 2004; Srivastava et al., 2008) caused by Chlamydia 
trachomatis infection. It is possible that the elevated IL10 gene expression level 
observed in the koalas with active chlamydial infection may have been in response to 
the high IFNγ expression. Also, IL10 has been suggested to prevent the 
inflammatory effects of cytokines such as the IFNγ and TNFα rather than merely 
inhibiting their transcription or translation (Conti et al., 2003). Moreover, it has been 
recently postulated that the host defence may be evolutionarily inclined towards Th2 
response in order to minimise Th1mediated damage to host (Miguel and Cherpes, 
2012). 
 
In order to fully appreciate the role of IFNγ during chlamydial infection in the koala 
and to associate a physiological significance to its expression levels, it would be 
important to consider factors such as the age and gender of animal, the site of 
infection and the strain of infecting C. pecorum. Also, the variable levels of IFNγ 
gene expression in individual animals may be due to the difference in the phase of 
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chlamydial infection in different animals. Hence, longitudinal samples from an 
animal through the course of its disease and resolution would provide a clearer 
picture. However, the IFNγ gene expression levels observed in this study suggest a 
pivotal role for this cytokine against C. pecorum defence mechanism in the koala. A 
comprehensive insight regarding the involvement of the Th1 or Th2 arm of the 
immune system in disease or resolution of chlamydial infection in the koala would 
further be achieved upon establishment of the source of the key Th1 and Th2 
cytokines, IFNγ and IL10 respectively, as they are produced by various cells/arms of 
the innate and adaptive immune system. In conclusion, the molecular analyses of the 
koala IFNγ sequence and qrtPCR assay described as part of this study, along with the 
previously reported IL10 and TNFα sequences and qrtPCR assays (Mathew et al., 
2013), are important assets that will not only support our ongoing attempts to 
investigate and conserve this native iconic species but will benefit wider efforts to 
study the efficacy and evolution of the immune systems of Australian marsupials. 
Understanding the immune response of this host, particularly the Th1 response, to 
chlamydial infections is critical if we are to appreciate the effect of interventions 
such as antimicrobial treatments (Markey et al., 2007) and targeted vaccinations 
(Carey et al., 2010; Kollipara et al., 2012, 2013) which will bring down the burden of 
disease in this species and assist in ongoing conservation initiatives. 
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Table 1. Pairwise comparison of koala IFNγ coding sequence with other animal 
species 
Animal Species % Identity 
Koala 100 
Opossum 74.4 
Platypus 53 
Human 61.1 
Rhesus Monkey 57.2 
Guinea Pig 55.6 
Mouse 51.3 
Elephant 61.9 
Armadillo 61.3 
Buffalo 61.2 
Camel 60.2 
Cat 58.2 
Dog 61.3 
Horse 62.5 
Chicken 46.7 
Pigeon 42.6 
Common Carp 36.1 
Gold Fish 37.3 
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Fig. 1. Koala IFNγ protein sequence alignment with human IFNγ sequence. The 
signal peptide is marked in a green rectangle and the signature sequence in a red 
rectangle. Potential N-glycolysation sites are denoted by green asterisks and the 
nuclear localisation sites are by red asterisks. 
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Fig. 2. The exon distribution and primer position of koala IFNγ gene when in 
alignment with the IFNγ gene of other species. The forward and reverse primer 
sequences used in the RT-PCR assays are highlighted in green and red, respectively. 
The PCR product has been designed such that it spans over an intron–exon junction. 
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Fig. 3. Phylogenetic tree of IFNγ nucleotide sequence constructed using Geneious 
Pro 5.6.5 (Drummond et al., 2012) using Jukes Cantor, Neighbour Joining tree build 
method with 1000 bootstrap repeat value. 
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Fig. 4. IFNγ gene expression in koala PBMCs stimulated with UV inactivated C. 
pecorum in Group I, II and III animals. Samples were collected at 0, 12, 24 and 48 h. 
Results are expressed as fold increase compared to GAPDH. 
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Abstract 
The koala (Phascolarctos cinereus) is an iconic Australian marsupial species that is 
facing many threats to its survival. Chlamydia pecorum infections are a significant 
contributor to this ongoing decline. A major limiting factor in our ability to manage 
and control chlamydial disease in koalas is a limited understanding of the koala’s 
cell-mediated immune response to infections by this bacterial pathogen. To identify 
immunological markers associated with chlamydial infection and disease in koalas, 
we used koala-specific Quantitative Real Time PCR (qrtPCR) assays to profile the 
cytokine responses of Peripheral Blood Mononuclear Cells (PBMCs) collected from 
41 koalas with different stages of chlamydial disease. Target cytokines included the 
principal Th1 (Interferon gamma; IFNγ), Th2 (Interleukin 10; IL10), and pro-
inflammatory cytokines (Tumor Necrosis Factor alpha; TNFα). A novel koala-
specific IL17A qrtPCR assay was also developed as part of this study to quantitate 
the gene expression of this Th17 cytokine in koalas. A statistically significant higher 
IL17A gene expression was observed in animals with current chlamydial disease 
compared to animals with asymptomatic chlamydial infection. A modest up-
regulation of pro-inflammatory cytokines, such as TNFα and IFNγ, was also 
observed in these animals with signs of current chlamydial disease. IL10 gene 
expression was not evident in the majority of animals from both groups.  Future 
longitudinal studies are now required to confirm the role played by cytokines in 
pathology and/or protection against C. pecorum infection in the koala. 
Keywords 
Koala, Chlamydia, TNFα, IFNγ, IL10, IL17A 
 136 Chapter 5:  
1. Introduction 
Chlamydia pecorum is an obligate intracellular Gram-negative bacterium, which has 
been associated with infection and disease in a wide range of animal hosts such as 
cattle, sheep, goats, and the koala (Longbottom and Coulter, 2003; Mohamad and 
Rodolakis, 2010; Polkinghorne et al., 2013). In the koala, chlamydial disease is a 
major contributing factor to localised extinctions of populations in Queensland and 
New South Wales; indeed a recent study indicated that chlamydiosis was a leading 
cause of admission to a wildlife care hospital in the latter Australian state, second 
only to trauma (Griffith et al, 2013). The associated disease caused by C. pecorum 
chronic infections contributes to the morbidity and mortality of the species via 
blindness, infertility and in severe cases, death (Polkinghorne et al., 2013).  These 
ocular, urinary, and genital tract pathologies somewhat mirror those seen in humans 
with C. trachomatis infections (Hemsley and Canfield, 1997). 
 
Studies of the pathogenesis of chlamydial disease in humans and animal models have 
shown that the host immunological response to chlamydial infection is the major 
determinant of protection, as well as immunopathology, of the associated disease 
(Entrican et al., 2004; Loomis and Starnbach, 2002; Mascellino et al., 2011). Even 
though protection against chlamydial infection has been traditionally associated with 
CD4+ mediated pro-inflammatory Th1 response concurrent with IFNγ secretion 
(Loomis and Starnbach, 2002; Hafner et al., 2008), recent studies in animal models 
have implicated the IL17A cytokine, secreted by the Th17 cell lineage, to have a 
similar role through neutrophil recruitment (Scurlock et al., 2011; Andrew et al., 
2013). The IL17A cytokine has been shown to play a role in the immune response to 
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extracellular bacteria (Ye, 2001) as well as intracellular bacteria (Lin, 2009). Being a 
biphasic bacteria, the potential role for the IL17A cytokine in chlamydial immunity 
has generated considerable interest. Studies involving respiratory (Zhou et al., 2009; 
Zhang et al., 2009; Bai et al., 2009; O’Meara et al., 2013a) and genital tract models 
of C. muridarum infection in mice (Scurlock et al., 2011; O’Meara et al., 2013b) 
have found IL17A production to be protective in the early stages of disease. Further, 
a predominantly Th2 response, dominated by anti-inflammatory IL10 secretion 
(Yang, 2001), has been implicated with the fibrotic reaction seen in chlamydial 
infection due to its suppressive effect on the Th1 response (Miguel et al., 2013).  
 
We have previously begun to evaluate the IFNγ, IL10 and TNFα cytokine profiles of 
koalas with current chlamydial disease versus a previous infection (Mathew et al., 
2013a; Mathew et al., 2013b). This analysis revealed a strong systemic response in 
animals with signs of current chlamydial disease. While general trends could be 
observed, the overall cytokine expression patterns were highly variable across 
groups, an observation that is not surprising given that: 1) the animals were from an 
out-bred population; 2) the level of disease expression varied; and 3) the time course 
of infection for each animal was unknown.  
 
Previous studies conducted in this field did not analyse the role played by IL17A in 
koala chlamydial disease due to an absence of sequence information and assays 
(Mathew et al., 2013a; Mathew et al., 2013b). Hence, the current study not only aims 
to investigate the role played by pro-inflammatory IL17A cytokine in koala 
chlamydiosis but also aims to analyse a larger cohort of koalas to identify cytokine 
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profiles that may be associated with protective versus disease-associated immune 
responses. The identification of these koala immunological profiles will help us 
understand why some animals experience only asymptomatic infection prior to 
clearance, versus those that develop debilitating immunopathology. 
 
2.0 Materials and Methods 
2.1 Ethics statement 
Queensland University of Technology (QUT) Animal Ethics Committee (Approval 
No. 0700000845) approved the collection and subsequent analysis of the koala blood 
and swab samples. Blood samples were collected by qualified veterinarians from 
wild-caught koalas captured as part of a larger field study in the Moreton Bay region 
of South East Queensland, Australia. Samples were collected from animals 
anaesthetised as part of a thorough health evaluation.  
 
2.2 Sample Collection 
 
Blood samples (5-6 mL) from 41 wild-caught anaesthetised koalas, were collected in 
EDTA and stored at 4oC for processing within 24 hours of collection. Swabs were 
collected from the conjunctiva of the left eye and right eye, urogenital sinus 
(females) and urethra (males) using aluminium shafted cotton tipped swabs (Copan, 
Interpath Services, Melbourne).  
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2.3 Koala lymphocyte proliferation, RNA extraction and reverse transcription assays 
Koala peripheral blood mononuclear cells (PBMCs) were harvested from the blood 
samples and suspended to a final concentration of 2 x 106 cells/ml in RPMI 1640 T 
cell media, as previously described (Mathew et al., 2013a). Cells mixed with equal 
volume of T cell mitogens PMA (1µg/ml) and Ionomycin (50ng/ml) were used as 
positive controls for lymphocyte proliferation. Koala PBMCs were stimulated with 
UV-inactivated C. pecorum G at 1/20 dilution to estimate cytokine production upon 
exposure to chlamydial antigens. RNA extraction and cDNA synthesis were 
completed from cells harvested at 0, 12 and 24 hours post-stimulation as described in 
Mathew et al., 2013a. 
 
2.4 Bioinformatic analysis 
Multiple sequence alignments were constructed using the Geneious Alignment 
program in the Geneious Pro 5.6.5 software and GeneDoc version 2.7.000 software. 
Predicted marsupial IL17A sequences were obtained from Ensembl: opossum 
(ENSMODT00000023892), Tasmanian devil (ENSSHAT00000014284) and wallaby 
(ENSMEUT0000005320). 
 
2.5 Cloning and sequence analysis of Koala IL17A mRNA sequence 
Primers were designed based on a homologous sequence alignment constructed 
using IL17A sequence from other marsupial species including the wallaby, opossum 
and Tasmanian devil. Using wallaby IL17A sequence as the reference, primers were 
designed targeting a 450bp sequence of the coding region. Conventional PCR was 
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performed on cDNA samples pooled together from PBMCs stimulated with 
PMA/Ionomycin at 12 and 24 hours, and unstimulated samples at 0 hours. After 
PCR amplification of a product of the expected size, this was cloned into a plasmid 
using the Promega pGEM-T Easy Vector Systems I as previously described 
(Mathew et al., 2013a) and sequenced at Australian Genome Research Facility using 
the AB 3730xl platform.  
 
2.6 IL17A qrtPCR assay design and optimisation 
The koala IL17A sequence identified was utilised to develop a qrtPCR assay with 
SYBR green I dye based chemistry to amplify a 282bp product of the koala IL17A 
coding sequence. Primer sequences for this reaction are as follows: IL17Af - 
GGAGTCTCAATGCCAAAGAGG, IL17Ar - GACGGAGTTCACGTGGTGGT. 
The primer pairs were designed to amplify a PCR product that spanned over two 
exons in order to avoid co-amplification of genomic DNA in the PCR reaction. 
 
A standard curve was constructed using serial dilutions with known concentrations 
of the 282bp PCR product to determine assay efficiency as previously described 
(Mathew et al., 2013a). Reactions were carried out in a Corbett Rotor Gene 6000 real 
time PCR machine at a final volume of 20 µl, with 1 unit of FastStart Taq 
Polymerase (Roche), 2 µl of 25mM MgCl2 (Roche), 2 µl of 10 x buffer (Roche), 0.6 
µl of 10 mm dNTPs (Roche), 3 µl of 1/10000 SYBR Green, 0.6 µl each of 10 mM 
forward and reverse primers each and 2 µl of template DNA. After an initial 
incubation of 95oC for 10 mins, 40 cycles of 20 s at 95oC, 25 s at 65oC and 25 s of 
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72oC were carried out for each IL17A qrtPCR. All samples were tested in duplicate. 
A mastermix with no cDNA was used as the no template control, and water was used 
as the negative control. 
 
A glyceraldehyde 3-phosphate dehydrogenase (GAPDH) qrtPCR assay described in 
Mathew et al. (2013a) was used as a reference gene for relative quantification. 
GAPDH has been chosen as the reference gene because of its relatively stable 
expression following stimulation with the mitogens as well as the test antigen used in 
this study. This finding has been confirmed by Maher et al. (2014) who reported 
GAPDH to be a suitable housekeeping gene for normalising cytokine expression by 
koala lymphocytes. The IL17A cytokine gene was normalised to GAPDH by the 2-
ΔΔCT method, where ΔΔCT = (Ct of target - Ct of GAPDH) at any time point - (Ct of 
target - Ct of GAPDH) at time zero hour (Livak and Schmittgen, 2001). 
 
2.7 Cytokine targets for analysis 
IFNγ, IL10, TNFα, and GAPDH mRNA expression levels were determined using 
optimised koala-specific qrtPCR assays, as previously reported (Mathew et al., 
2013a; Mathew et al., 2013b). The qrtPCR primers used in this study are summarised 
in Table 1. Prior to this study, the koala IL17A sequence was not known and so no 
IL17A assay was available.   
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2.8 C. pecorum infection status via PCR and western blot  
The koalas captured as part of this study were screened for the presence of current or 
previous C. pecorum infection via two approaches: 1) 16SrRNA C. pecorum species-
specific qrtPCR assays applied to swab samples collected from the conjunctiva and 
urogenital sinuses of koalas (Wan et al., 2011); and 2) for the presence of Chlamydia 
specific antibodies in plasma using C. pecorum His-tagged major outer membrane 
protein (MOMP) A, F and G western blot screening (Kollipara et al., 2012). 
 
2.9 Statistical analysis 
Mann Whitney U test with a P value set at 0.05 was used to analyse the significance 
of target cytokine gene expression in Group I/ No Disease vs Group II/ Diseased 
with reference to GAPDH. Statistical comparison between different cytokine gene 
expressions within a group was performed using the Wilcoxon matched pair test. 
Graph-Pad Prism version 5 (Graph Pad Software, Lajolla, CA, USA) was used to 
perform statistical analyses.  
 
3.0 Results 
3.1 Koala IL17A nucleotide sequence identification 
Prior to the commencement of this study, no sequence or assays were available for 
measuring the koala IL17A immune response. For this purpose, we cloned and 
sequenced the coding region of koala IL17A. Using primers designed to conserved 
regions of the predicted opossum, wallaby and Tasmanian devil IL17A sequences, a 
462 base pair partial IL17A mRNA sequence was identified following PCR 
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amplification and sequencing (GenBank under Accession number KJ174517). Not 
surprisingly, similar to the sequences for other koala cytokines that we recently 
reported (Mathew et al, 2013a & b), koala IL17A shares greatest similarity to the  
algorithm-predicted gene sequences for marsupial IL17A sequences of the tammar 
wallaby (89.4%; ENSMEUT0000005320), opossum (84.2%; 
ENSMODT00000023892) and Tasmanian devil (83.8%; ENSSHAT00000014284) 
compared to experimentally-verified mammalian (e.g. Human –69%; GenBank ID - 
BC067505) or avian sequences (e.g. Chicken – 51.7%; GenBank ID - AM773756).   
 
3.2 IL17A qrtPCR assay development and optimisation 
A koala-specific IL17A qrtPCR was developed to measure IL17A gene expression in 
the peripheral blood of the koala. The primers were designed to span over at least 
one intron-exon junction to avoid co-amplification of any residual genomic DNA. 
IL17A gene expression was measured at 0, 12, and 24 hours in: 1) unstimulated 
koala PBMCs; 2) PBMCs stimulated with PMA/ Ionomycin; and 3) PBMCs 
stimulated with UV-inactivated C. pecorum strain G.  In many of the animals there 
was no observable IL17A gene expression in unstimulated PBMCs at 0 hours. For 
the purpose of analysis, these samples were assigned to have a Ct value of 30. The 
reaction has a detection limit of approximately 2 copies at a threshold of 
approximately 30 cycles (data not shown). Hence, the samples with no detectable 
IL17A at 0 hours in unstimulated samples were assigned a Ct of 30 to enable use of 
the 2-ΔΔCT method and as such enabling comparison of expression levels amongst the 
different cytokines. 
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Following assay optimization, an R2 value of 0.99 and reaction efficiency of greater 
than 90% was observed in all subsequent PCR runs. Reproducibility of the assay was 
measured and confirmed by comparing the Ct values of standards in consecutive 
runs, which were found to be similar. These parameters illustrated that the IL17A 
qrtPCR assay was optimised and could be used for quantification of this gene in an 
unknown sample. 
 
3.3 Characterisation of the current and previous Chlamydia infection status of 
asymptomatically infected and diseased koala cohorts  
Forty one koalas were captured, clinically examined and sampled as a part of an 
ongoing study of healthy koalas in a wild population in South-East Queensland. At 
the time of sampling, 12 of these animals displayed evidence of chlamydial disease 
(Group II; Table 3), with 11 animals presenting with cystitis only with no evidence 
of ocular disease, while the remaining one animal had conjunctivitis only. The 
remaining 29 animals displayed no signs of chlamydiosis (Group I; Table 2).  
 
To investigate their current or previous chlamydial infection status, C. pecorum 
species-specific qPCR assays and/or anti-C. pecorum MOMP Western blots were 
performed (Table 2 and 3). Initially, the animals were screened using the 16S rRNA 
qrtPCR. The qrtPCR negative animals were then also screened by MOMP western 
blot. Of the 41 animals studied, only three animals were negative for C. pecorum 
16S rRNA, however, these animals tested positive for MOMP antibody via Western 
blot screening, indicating that they had seen a previous infection. Based on these 
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results and the presence of clinical signs of chlamydiosis, the 41 koalas were 
grouped as follows: Group I/ No Disease (n = 29) – C. pecorum PCR and/or western 
blot positive without overt signs of chlamydiosis; Group II/ Diseased (n = 12) – 
koalas with current signs of chlamydiosis and C. pecorum PCR positive. Evaluation 
of the presence or absence of clinical signs of chlamydiosis was performed by 
experienced veterinarians from Endeavour Veterinary Ecology, (EVE) Toorbul, 
Australia. Group II/ Diseased animals were further classified into koalas with active 
(n=9) and inactive (n=3) disease based on the veterinary evaluation and chlamydial 
disease scoring criteria recommended by Wan et al. (2011). The presence of pyuria 
and suppurative exudate at the ocular and urogenital site was considered to be 
characteristic of active chlamydial disease. The presence of inflammatory cells in the 
urine sediment of koalas with cystitis was a further indication of active disease. 
Inactive chlamydial disease was classified as disease in the absence of these 
additional features.   
 
Of the 29 animals included in Group I/No Disease, 26/29 of the animals in this group 
were PCR positive for C. pecorum DNA. For all but one of these PCR positive 
animals, C. pecorum DNA could be detected at both the UGT and at least one of the 
two ocular sites. The exception to this group of PCR positive animals was one koala 
(My), who was found to be PCR positive in both eyes but negative for C. pecorum in 
the UGT. The remaining three animals in this group that were PCR negative, 
however, were found to be serology positive using our C. pecorum MOMP Western 
blots (Table 2; data not shown). 
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For the 12 animals in Group II/Diseased (Table 3), all animals were found to be PCR 
positive in the UGT. Ocular shedding was less common, however, with C. pecorum 
DNA detected in only one animal with cystitis (Barry) and in an animal (Beauty) 
with signs of unilateral conjunctivitis in the right eye (Table 3).   
 
3.4 Expression profiling of the IFNγ, IL10, IL17A and TNFα responses of 
Chlamydia-infected koalas with or without clinical disease 
 
In order to evaluate the immune-recognition and systemic cytokine response of 
koalas with current or previous C. pecorum infection, PBMCs isolated from the 
koalas were stimulated with UV inactivated, semi-purified C. pecorum G for 12 and 
24 hours. IL17A, TNFα, IFNγ, and IL10 gene expression was measured as 
previously described (Mathew et al., 2013a; Mathew et al., 2013b). With one as the 
base line for unstimulated PBMCs at 0 hour, fold increase in gene expression was 
measured for each cytokine of interest.  
 
Duplicate stimulation experiments were performed with PMA/ Ionomycin 
stimulation to evaluate cell viability and to generate positive controls for our 
qrtPCRs. PMA/Ionomycin has been found to be an effective mitogen to stimulate 
koala PBMCs in a recent study (Maher et al., 2014). Strong expression, defined as a 
> 50 fold increase in expression following stimulation, could be observed in at least 
one cytokine (TNFα, IFNγ and IL17A) for the majority of koalas (38/41, 92%). IL10 
expression, on the other hand was lower compared to the other cytokines across both 
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cohorts, with an average fold change < 10 for all but four of the 41 animals. The 
latter four animals also expressed high levels of one of the other three cytokines.  
 
When PBMCs from Group I/ No Disease (n=29) animals with evidence of current or 
past C. pecorum infection in the absence of chlamydial disease were stimulated with 
UV inactivated C. pecorum G, significant variation in the cytokine responses were 
observed. The geometric mean, median and range of the four cytokines quantified 
for the animals in this cohort is summarised in Table 4. Of the 29 animals analysed 
in Group I/ No Disease, a very low IL17A gene expression ranging between 0 – 1 
was observed in 16 animals (55%) following exposure to C. pecorum. Koalas which 
had a gene expression of 0 for IL17A, were assigned the fold increase as 0.01, which 
is the lowest detectable fold increase in the cohort of koalas included in this study.  
For 11 of the 29 koalas, IL17A transcripts could only be detected following antigen 
stimulation and not at the 0 hour time point. Seven of the 29 koalas (24%) koalas did 
not have any detectable IL17A transcription within 24 hours of C. pecorum 
stimulation.  
 
Amongst the other cytokines analysed, the lowest fold change increase was observed 
for IFNγ gene expression with a geometric mean of 2.1 and fold change ranging  
between 0.02 – 364.6. When comparing the expression profiles of each of the 
cytokines in this group, TNFα gene expression was found to be significantly higher 
(p<0.05) than the expression of IFNγ and IL10. There were no statistically 
significant difference in the IL17A expression within Group I/ No Disease.  
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Similar to the Group I/No Disease animals, there was considerable animal-to-animal 
variation in the cytokine responses of Group II/Diseased animals with signs of 
current chlamydial disease and evidence of an ongoing C. pecorum infection (n=12), 
however, some trends could be observed (Table 4). The strongest expression results 
for animals in this group following C. pecorum antigen stimulation were for IL17A, 
with a geometric mean of 34.8 and fold change range of 1.4 - 445. A relatively lower 
IL17A expression was observed only for one animal with conjunctivitis (2.0 fold 
change) and another two animals whose expression response for all the tested 
cytokines was relatively low. The observed fold change in gene expression for 
IL17A was significantly higher than that observed for IL10 (p<0.03) and TNFα as 
well (p<0.01). Though not statistically significant, a general trend of higher IL17A 
gene expression was observed in koalas with active chlamydial urogenital disease 
than in animals with inactive disease. 
 
When comparing the gene expression profiles of the two cohorts together, IL17A 
expression was found to be significantly “stronger” in the Group II/Diseased group 
animals (p<0.009). There were otherwise no statistically significant differences 
between the cytokine gene expressions of both groups, although a general trend 
towards proinflammatory cytokine secretion was observed in the Group II/Diseased 
animals (Table 4). Hence, the key difference in the cytokine profile of the two 
groups was a statistically significant IL17A gene expression amongst the diseased 
group of animals. 
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Discussion 
Chlamydia is a bacterium with a complex biphasic development cycle, involving 
inter-conversion between extracellular and intracellular forms. It has been 
hypothesised that the response to both these intracellular and extracellular 
developmental forms requires a balanced Th1 and Th2 response (Darville and Hiltke, 
2010). Several recent studies have also suggested a seminal role for Th17 in 
chlamydial pathogenesis (Andrew et al., 2013; O’Meara et al., 2013a; O’Meara 
2013b). However, extensive studies in humans are yet to truly understand the natural 
immune response to this obligate intracellular bacterium (Geisler, 2010), let alone 
the differences that will influence a protective versus pathological outcome (Agrawal 
et al., 2009).  
 
In the current study, we performed a cross-sectional profiling of Chlamydia-infected 
koalas with and without evidence of chlamydial disease by measurement of a range 
of important cytokine gene markers. Though not statistically significant, a trend 
towards a higher pro-inflammatory cytokine profile was observed in Group 
II/Diseased animals when compared to the Group I/No Disease animals. Although 
the immune response of animals within each cohort was highly variable, significant 
differences were observed in the IL17A response of koalas in Group I/No Disease 
and Group II/ Diseased, with animals in the latter group showing strong increases in 
IL17A gene expression following exposure to C. pecorum antigen. Although we do 
not have cell-specific markers for koalas, the strong fold-change in expression of 
these koalas suggests that diseased koalas have high levels of Th17 cells in their 
peripheral blood. In other animal models, αβ T cells, γδ T cells, invariant Natural 
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Killer T cells (iNKT) cells, Lymphoid Tissue inducer (LTi)-like cells, natural killer 
cells and macrophages are also known to produce IL17A (Cua and Tato, 2010; Jin 
and Dong, 2013). In animal models of chlamydial infection, IL17A has been shown 
to aid Th1 immunity development and neutrophil recruitment (Scurlock et al., 2011).  
 
IL17 and IFNγ have been shown to have a synergistic effect on the up regulation of 
iNOS and NO production (Zhang et al., 2012), however, they appear to have 
opposing functions when it comes to neutrophil recruitment (Savarin et al., 2012). 
Similar to IFNγ, nevertheless, IL17A has also been implicated in immunopathology, 
with evidence observed of increased recruitment of inflammatory cells such as 
neutrophils and macrophages and increased expression of matrix metaloproteinases 
at the site of infection (Andrew et al, 2013; O’Meara et al., 2013b). While we have 
no direct ability to currently assess these inflammatory factors in the koala,  the 
relatively higher IL17A gene expression observed predominantly in animals with 
active chlamydial disease, evidenced by suppurative exudation and inflammatory 
cells in urine sediment,  as opposed to inactive disease in Group II/Diseased animals 
(Table 3) could be consistent with this “over-amplification” of the inflammatory 
response to the presence of the infection, especially in light of the low expression of 
IFNγ and IL10 in these animals.  
 
Observations similar to our study have been reported by Jha et al. (2011) who 
showed greater expression of IL17A in comparison to IFNγ in the cervical washes of 
women with C. trachomatis cervicitis. Contrary observations have also been 
described (Barral et al., 2014) which can be attributed to the differences in the study 
population; the former looked at cases of cervicitis whereas the latter focused on 
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asymptomatic infection. However, vaccination has been reported to be less effective 
in the absence of IL17A in a mouse model of C. muridarum genital tract infection 
(Andrew et al., 2013). Similarly, IFNγ/ IL17A double positive CD4+ T cells 
correlated with improved protection against chlamydial infection in a vaccine study 
(Yu et al., 2010).  While clearly more studies are needed to determine the role of 
IL17A in chlamydial disease pathology, our study does indicate an important role for 
IL17A gene expression in chlamydial disease development in the koala.  
 
Similar to our previous studies (Mathew et al., 2013a; Mathew et al., 2013b), a 
comparatively strong expression of TNFα and IFNγ, normally associated with 
protection, was observed in animals with current signs of chlamydiosis (Group II) 
and not in animals without any sign of disease (Group I). This is not surprising as the 
very immune responses which are associated with protection against members of the 
genus Chlamydia have also been implicated in disease pathology (Loomis and 
Starnbach, 2002). To explain this phenomenon, it has been hypothesized that the 
possibility of a persistent phase of chlamydial infection (Hogan et al., 2004) and the 
biphasic life cycle of the organism provides avenues to escape the pro-inflammatory 
immune response of the host and to set in motion a chain of intermittent Th1 and 
Th2 immune responses through the course of its developmental cycle, eventually 
leading to the tissue damage and irreversible sequelae associated with chronic 
chlamydial disease as observed in the Group II/Diseased animals in this study 
(Mascellino et al., 2011). However, IL10, which has been noted to mitigate the 
damaging effects of the pro-inflammatory response was at low expression in both the 
groups analysed in our koala study. This could be due to fewer IL10 producing cells 
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in the peripheral circulation as a low IL10 expression was also noted following 
mitogen stimulation in all the studied animals.  
 
Marked variations in cytokine response could also be observed in animals included 
in Group I/No Disease and Group II/Diseased, as previously observed (Mathew et 
al., 2013a; Mathew et al., 2013b), despite the increase in the cohort sizes in this 
study. Again, this is not surprising as the koalas were likely to have been infected at 
variable points of time and could essentially be at different stages of infection. While 
logistically challenging in naturally infected wild animals, longitudinal studies 
involving assessment of koala infection and health status will need to be undertaken 
to understand the exact role that these cytokines have on infection and disease 
progression. Controlling for the fact that koalas are an outbred population will be 
more challenging.  In humans, genetic variability in the HLA class I and II genes 
(Geisler et al., 2004) and IL10 promoter gene polymorphisms (Wang et al., 2005) 
have been linked to increased susceptibility or protection against C. trachomatis 
infection. Targeting island koala populations with lower genetic diversity (Lee et al., 
2013) in future studies can help control for the genetic variation observed in outbred 
koala populations; thereby helping to understand its contribution to the variable 
immune response observed. 
 
 Beyond further studies to delineate the populations of immune cells in systemic 
circulation that may be involved in the koala response to chlamydial infection, it will 
also be important to understand local immune responses to this mucosal pathogen. It 
has been previously demonstrated that significant variation exists in the in vitro 
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immune response elicited by PBMCs when compared to lymphocytes from the site 
of actual infection during C. trachomatis infection (Vats et al., 2007).  Hence, assays 
targeting the mucosal site of infection will help in better understanding the immune 
response of koala chlamydial infection. Future studies would also benefit from 
incorporation of age and sex matched control animals without history of previous 
chlamydial infection; however obtaining uninfected wild animals remains a major 
challenge. Another variable that will need to be considered in these studies includes 
(a) the effect of anaesthetics, known to influence cytokine expression pattern 
following in-vitro mitogen stimulation of lymphocytes in humans (Schneemilch et 
al., 2004), or (b) physiological stress (Abraham, 1991), on koala cytokine gene 
expression as little or nothing is known about either for this native species.  
 
This study has provided us with important baseline data that will assist in 
understanding chlamydial disease pathogenesis and protection, a key consideration 
for the development of a safe and effective chlamydial vaccine. The koala specific 
immunological tools developed in this study for IL17A, alongside our previously 
described TNFα, IFNγ and IL10 assays, will be critical for the subsequent work but 
may also eventually form a part of a immunological “toolkit” (Maher et al., 2014; 
Morris et al., 2014) that could be available to stakeholders to assess the health status 
and impact of chlamydial infections in affected koala populations.  
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Table 1. qrtPCR primers for TNFα, IFNγ, IL17A, IL10 and GAPDH 
Gene  Forward Primer 5’-3’ Reverse Primer 5’-3’ Target 
TNFα GAGACGTAGAGCTAGCAG TGCCAAGAAAATCTGTGGAC 180bp 
IFNγ AGCTACCTCTTAGCATCC TCCTCTTTCCAA CGATCC 167bp 
IL17A GGAGTCTCAATGCCAAAGAGG GACGGAGTTCACGTGGTGGT 282bp 
IL10 TGGGCTCTTTAGGCGAGAAG CAGGGCAGGAATCTGTGACA 72bp 
GAPDH GGACTCATGACCACAGT CCATCACGCCACAGC 70bp 
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Table 2. PCR, Western Blot and cytokine gene results for animals included in the 
Group I/ No disease in this study.  
Animal 
16S qPCR Western Blot Fold increase 
LE RE UGT A F G TNFα IFNγ IL17A IL10 
Mel G NEG NEG NEG NEG POS NEG 151 35.7 0.01 6.7 
Slocombe NEG POS POS - - - 101.8 1.2 200.8 33.5 
Caz NEG NEG NEG NEG NEG POS 4 0.4 0.01 4.9 
Julia NEG POS POS - - - 0.9 0.5 71.5 5.3 
Lexi NEG NEG NEG NEG NEG POS 24.5 53.4 162 2.0 
My POS POS NEG - - - 112.2 199.4 0.01 38.0 
Cindy NEG NEG POS - - - 88 3.9 71 8.7 
Nat NEG POS POS - - - 5.2 1.3 238.8 24.4 
Sarah NEG NEG POS - - - 27.6 0.6 0.01 8.6 
Kate G NEG POS POS - - - 36.2 364.5 15.6 7.9 
Doddy POS POS POS - - - 270.5 9.2 0.01 2.7 
Susan POS POS POS - - - 116.1 0.1 0.6 0.2 
Cougar NEG NEG POS - - - 93.7 0.9 10.3 9.0 
Karen NEG NEG POS - - - 107.6 14.8 2.1 11.7 
Matt NEG NEG POS - - - 11.3 0.5 337.7 5.0 
Lindsay NEG NEG POS - - - 18.1 0.7 0.2 4.8 
Cate NEG NEG POS - - - 7.9 1.2 0.01 10.3 
Bubbles NEG NEG POS - - - 1.5 49.1 0.8 21.1 
Tash POS POS POS - - - 3.2 1.6 14.8 2.4 
Gav POS POS POS - - - 0.1 1.1 0.01 1.5 
Bev POS POS POS - - - 15.8 0.5 0.4 2.3 
Salvatore NEG POS POS - - - 1.9 3.2 0.01 19.9 
Frances POS POS POS - - - 0.3 0.2 165.4 3.7 
Mark POS POS POS - - - 1.3 1.3 0.01 0.5 
Daryl NEG NEG POS - - - 1.4 3.5 0.01 1.2 
Robyn NEG NEG POS - - - 20.9 0.5 4.9 3.9 
Mango NEG NEG POS - - - 10.1 2.6 22.8 14 
Minky NEG NEG POS - - - 3.5 0.5 0.1 2.8 
Coco NEG NEG POS - - - 0.9 0.02 0.01 2.3 
LE - Left Eye, RE – Right Eye, NEG- negative, POS- positive. A, F and G are three C. 
pecorum MOMP (Major Outer Membrane Protein) aminotypes described in eastern 
Australia by Kollipara et al (2013). POS/NEG by 16S qPCR indicates the 
presence/absence of C. pecorum DNA at the site. POS/NEG by western blot for A, F 
and G aminotypes indicates presence of specific antibodies to these strains in the sera of 
the koala. ‘-’ sign indicates animals for which western blot was not done when they were 
positive by 16SrRNA qPCR. The fold increase in gene expression is calculated by 2-ΔΔCT 
method as described in section 2.6. 
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Table 3. 16S qPCR and cytokine gene results for animals included in the Group II/ 
Diseased in this study. 
 
Animal Disease 
16S qPCR Fold increase 
LE RE UGT TNFα IFNγ IL17A IL10 
Curry Chronic active cystitis NEG NEG POS 25.9 1.2 153.2 32.6 
Poma Chronic active cystitis NEG NEG POS 14.6 0.0 286 2.3 
Mali 
Subclinical active 
cystitis 
NEG NEG POS 2.2 3.7 1.3 2.8 
Delores Chronic active cystitis NEG NEG POS 35.2 2.0 445.7 2.8 
Circe Chronic active cystitis NEG NEG POS 32.4 831.7 137.1 1.2 
Barry Acute active cystitis NEG POS POS 32 12.9 103.2 129.7 
Harley 
Subclinical active 
cystitis 
NEG NEG POS 8.8 33.1 63.1 0.5 
KP Chronic active cystitis NEG NEG POS 27 5.5 49.5 13.0 
Rambo Chronic inactive cystitis NEG NEG POS 13.9 56.1 16.7 15.0 
Pinki Chronic inactive cystitis NEG NEG POS 6.3 4.0 18.6 10.3 
Andrew 
Sub-acute inactive 
cystitis 
NEG NEG POS 5.9 6.6 4.1 1.2 
Beauty 
Chronic active 
conjunctivitis 
NEG POS POS 45.2 1.0 1.9 16.7 
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Table 4. Geometric mean, median and range of the four cytokines quantified in 
the Group I and Group II animals 
 Group 1/No Disease Group 2/ Diseased 
Number of koalas 29 12 
TNFα 
Geometric mean
1
 
Median 
Range 
 
10.1 
11.3 
0.1 – 270.6 
 
14.5 
14.7 
2.5 - 45.3 
IFNγ 
Geometric mean
1
 
Median 
Range 
 
2.1 
1.3 
0.02 - 364.6 
 
5.8 
4.8 
0.5 - 86.2 
IL17  
Geometric mean
2
 
Median 
Range 
      
0.7 
0.6 
0.01 – 337.8 
 
34.8 
56.3 
1.4 – 445.7 
IL10 
Geometric mean
1
 
Median 
Range 
 
5 
5.04 
0.3 – 38.1 
 
6.0 
6.6 
0.6 – 129.8 
 
1 No statistically significant difference was observed for expression between Group I vs 
Group II for TNFα (p=0.57), IFNγ (p=0.08) and IL10 (p=0.87). 
2 Differences between the IL17 gene expression for Group vs Group II are statistically 
significant (p=0.09). 
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6.1 Summary 
The koala is an iconic arboreal marsupial, which is valued for its position in the 
unique bio-diversity of Australia as well as its contribution to the tourism industry. 
However, throughout the history of European settlement in Australia in the early 
1800s and continuing to the present day, its survival is threatened by a number of 
anthropogenic and natural factors. The major threat to the survival of koala in the 
late nineteenth century, which led to severe population crashes, was excessive 
hunting for koala pelts which was a priced commodity in the thriving international 
market (Martin and Landasyde, 1999). After many populations had been shot to 
extinction, the koala was conferred ‘protected species’ status by many states and 
conservation initiatives were undertaken. In spite of these initiatives the challenges 
of koala survival have continued. The indirect effect of human interventions such as 
urbanisation leading to koala habitat destruction/fragmentation, road accidents and 
dog attacks have continued to threaten existing koala populations. Shrinking koala 
numbers are further affected by debilitating infectious diseases such as chlamydiosis.  
 
Chlamydial disease is of high prevalence and severity in many Australian koala 
populations. C. pecorum and C. pnuemoniae have been isolated from clinical cases 
in the koala, the former strain being associated with widespread and more pathogenic 
states of disease (Jackson et al., 1999). The high susceptibility of many koala 
populations to chlamydial disease has long been attributed to ‘stress’ (Melzer et al., 
2000).  However, no scientific studies have been conducted to substantiate these 
views in animals subjected to environmental or nutritional stress or stress due to 
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overcrowding. Even claims of the koala being an ‘immunologically lazy’ animal and 
hence susceptible to infectious disease (Wilkinson et al., 1992) have not been 
substantiated, with more recent studies clearly showing that koalas can mount a 
strong humoral as well as CMI response (Carey et al., 2010; Kollipara et al., 2012; 
Kollipara et al., 2013b).  
 
Nonetheless, there is no doubt that chlamydiosis is wide spread in many Australian 
koala populations and poses a serious threat to the survival of the species. So far, 
studies in this field have largely focused on epidemiology of the disease (Kollipara et 
al., 2013c), treatment methodologies (Griffith et al, 2010) and prophylactic and 
therapeutic vaccine development initiatives (Carey et al., 2010; Kollipara et al., 
2012; Kollipara et al 2013a; Kollipara et al., 2013b). However, in order to appreciate 
the efficacy of disease management initiatives such as vaccination, it is important to 
understand host-pathogen interaction. Any effort in this field has been limited by the 
non-availability of species specific immune assays. 
 
Cross reacting non-species specific immune assays have been trialled previously to 
understand the koala immune system, particularly the pathology of Chlamydia in the 
koala (Higgins et al. 2004; Higgins et al., 2005). It is known from the studies in 
small animal models of Chlamydia and in humans, that a Th1 dominated response is 
associated with protection against the pathogen whereas a predominantly Th2 
response leads to chronic disease manifestations and development of fibrosis 
(Darville and Hiltke, 2010). As a first step to investigate the Th1/Th2 response of the 
koala during chlamydial disease, Higgins et al. (2004) used anti-bovine IL4 and 
IFNγ to label corresponding koala cytokines. Even though there was evidence of 
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cross reactivity between the commercial anti-bovine IFNγ and an intracellular 
product of the koala lymphocyte, its specificity was not established in the study. In 
addition, the anti-bovine IL4 did not exhibit any cross reactivity at all. However, the 
anti-bovine IFNγ antibody has not been used so far in the evaluation of natural 
chlamydial disease in the koala. Another study investigating the role of antibody 
response in koala chlamydial disease revealed elevated anti-heat shock protein titres 
in Chlamydia infected koalas with fibrous occlusion of the uterus or uterine tube 
(Higgins et al., 2005), thereby providing evidence of a Th2 mediated association in 
host immune response. However, in the absence of cytokine assays and other 
immune cell markers, this study could not establish the role played by Th1 cells in 
the pathogenesis of chlamydiosis in the koala.  
 
Along with understanding the immunobiology to natural chlamydial infection in a 
host, it is also important to understand the immune response of the host to vaccine 
development initiatives. An ideal vaccine should induce immune responses which 
are protective and do not result in immunopathology or persistence induction in the 
host. C. trachomatis vaccine development initiatives in the murine model of 
infection have focused on antigen/adjuvant combinations which would stimulate and 
maintain a Th1 mediated cytokine response thereby rendering protection to the host 
(Brunham and Rey-Ladino, 2005). The vaccine trials targeting chlamydiosis of the 
koala caused by C. pecorum have evaluated the humoral immune response by using 
koala specific IgG ELISA to quantify vaccine antigen specific responses, C. 
pecorum neutralizing antibodies in systemic circulation and CMI response using 
lymphocyte proliferation assays (Carey et al., 2010; Kollipara et al., 2012; Kollipara 
et al., 2013a). Even though these tools have indicated a strong humoral as well as 
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CMI response against the vaccine antigens in the koala, they were unable to 
differentiate between a Th1 and Th2 CMI response, and hence unable to recognize 
the protective immunobiology of the vaccine.  
 
As C. pecorum is a biphasic bacteria with an intracellular phase, development of 
cytokine assays to investigate the CMI response of the koala to chlamydial infections 
becomes important. As part of my current study, it was aimed to sequence and clone 
key cytokines which are known to play an important role in chlamydial pathogenesis 
in the human chlamydial infection as well as in animal models. Further, the cytokine 
sequence information was used to develop quantitative Real Time PCR (qrtPCR) 
based assays, enabling their systemic gene transcription levels to be measured in 
koalas with current signs of chlamydial disease as well as in koalas with chlamydial 
infection in the absence of apparent disease.  
 
Initially in this study, TNFα, IL10, IFNγ and IL17A were chosen as the cytokines of 
interest. Cytokines such as TNFα and IL10 are >80% conserved in placental 
mammals. The conserved nature of these cytokines coupled with the availability of 
other marsupial sequences enabled primer design for PCR, subsequent cloning and 
sequencing of koala TNFα and IL10 (Chapter 3). The low level of sequence 
conservation for IFNγ coupled with a shortage of other marsupial IFNγ sequences at 
the start of this study hindered our efforts at cloning and sequencing of the koala 
IFNγ sequence (Chapter 4). However, with the availability of koala transcriptome 
data (unpublished data), the IFNγ sequence was obtained and developed into a 
qrtPCR assay. Similar to TNFα and IL10, koala IL17A was cloned and sequenced 
using primers designed based on orthologous sequence (Chapter 5). A phylogenetic 
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tree constructed using these newly sequenced cytokines shows that the koala 
sequences cluster together with other known orthologous marsupial cytokines 
(Figure 1) forming a clade similar to other mammalian species.  
 
Figure 1. . Phylogenetic tree of TNFα, IFNγ, IL10 and IL17A cytokine sequences 
constructed using Geneious Pro 6.0.6 using Jukes Cantor, Neighbour Joining tree 
build method with 1000 bootstrap repeat value. 
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Detectable differences in the CMI response of the koala with and without current 
chlamydial disease, were observed in this study. If susceptibility or resistance to C. 
pecorum disease in the koala is dependent on the differences in CMI response, our 
study has provided a foundation to understand these variances. The data presented in 
Chapter 3 and 4 which evaluated the systemic gene expression of TNFα, IL10 and 
IFNγ in a group of 10 koalas clearly shows a statistically significant difference 
between animals with current chlamydial disease and animals with past or no history 
of chlamydial infection. However, when the same assays were used to analyse the 
cytokine profile of a different cohort of koalas in Chapter 5, though the general trend 
towards a pro-inflammatory cytokine response consisting of TNFα and IFNγ gene 
transcription was observed, the results were variable for individual animals and not 
statistically significant. Nonetheless, in this cohort of wild koalas studied, IL17A 
gene expression was the distinguishing immune response factor between koalas with 
active chlamydial disease and koalas with evidence of current/past C. pecorum 
infection in the absence of any disease. In both groups of koalas evaluated in this 
study, the IL10 response was markedly low in comparison to the other cytokines 
studied.  
 
A schematic presentation of the likely cytokine responses and the resulting disease 
manifestations in a C. pecorum infected koala is described in Figure 2 based on 
inferences from data of the current study. The figure describes the possible 
progression of untreated C. pecorum infection/ disease or its resolution in the koala 
based on the expression levels of the four cytokines studied as part of this project. 
The disease scores have been assigned based on the scoring criteria used to assess 
the chlamydial disease chronicity in the koala as described by Wan et al (2011). The 
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disease scores from 0 – 3 depict the following chlamydial infection/ disease 
conditions in the koala: 0 - no detectable disease; 1- acute or subacute disease 
without marked structural changes; 2 – chronic disease without evidence of active 
disease characterised by little or no discharge; 3 – chronic active disease 
characterised by suppurative exudation. 
 
Much of the information relating to chlamydial disease pathogenesis is obtained 
from animal studies, principally the mouse model. Even though there are differences 
in the chlamydial infection model between mice and humans, the former is the 
preferred experimental animal to understand host-pathogen interaction during 
chlamydial infection. The mice model mimics many aspects of acute chlamydial 
infection in humans (Morrison and Caldwell, 2002); however, there are significant 
differences to be considered as well. Firstly, in mice the infection is self - limiting 
and manifests after a single challenge; whereas humans can develop chronic 
chlamydial infection if untreated and undiagnosed (Miyairi et al., 2010). Moreover, 
mice have to be pre-treated with progesterone to enhance their susceptibility to 
infection and synchronise the diestrus which inadvertently alters the genital tract to a 
non-protective Th2 phenotype (Larsen and Hwang, 2011).  
 
A Th1 response has been associated with protection from infection in both mice and 
humans, though it does not provide protection from pathology in the humans (Perry 
et al., 1997; Agrawal et al., 2009; Rank and Whittum-Hudson, 2010). This could be 
due to the chronic nature of human chlamydial infection. A predominantly Th2 
response does not provide protection from infection in both mouse and humans 
(Wang et al., 1999; Yang, 2001). Because of the ethical considerations of an 
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untreated longitudinal study in humans, most of the evidence relating to protective 
immunity is indirect. These studies have also indicated that local Th1 cytokines, 
mainly IFNγ is associated with Chlamydia infection (Batteiger et al., 2010). 
Moreover, it has been postulated that it is a balanced immune Th1/ Th2 immune 
response, which leads to infection resolution without much damage to the host 
(Debattista et al., 2003; Mascellino et al, 2011). Recent studies in animal models 
have implicated the IL17A cytokine, secreted by the Th17 cell lineage, to have a 
similar role to IFNγ through neutrophil recruitment (Scurlock et al., 2011; Andrew et 
al., 2013). The role played by Th17 cells in human chlamydial infection and 
pathology is yet to be understood. As no previous studies have looked at the cytokine 
response in the koala, based on evidence from animals and human studies and 
indications from our data an interplay between the four cytokines analysed in this 
study can be attributed to the chlamydial disease outcome and has been presented in 
Figure 2. 
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Disease Score 0 Disease Score 0 
Disease Score 1 
Infection 
Disease 
↑IFNγ, ↑TNFα, ↑IL10, ↑ IL17A 
 
↑IFNγ, ↑TNFα, ↓IL10, ↓IL17A ↑IL10,↓IFNγ, ↓TNFα, ↓IL17A 
↑IFNγ, ↑TNFα, ↓IL10, ↓IL17A 
↓↓IL10, ↑↑IFNγ, ↑↑TNFα, ↑↑IL17A 
↑↑↑IL17A, ↓↓IL10, ↑TNFα, ↑IFNγ 
Figure 2. Schematic presentation of infection and disease process in response to C. pecorum  infection in the koala based on 
inferences from the data generated as part of this study. The disease scores are assigned based on the scheme published in Wan et 
al., 2011. Disease score 0 - no detectable disease; 1- acute or subacute disease without marked structural changes; 2 – chronic 
disease without evidence of active disease characterised by little or no discharge; 3 – chronic active disease characterised by 
suppurative exudation. 
Disease Score 1 
Disease Score 2 
2 
Disease Score 3 
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At the onset of C. pecorum infection in the koala, a balanced response of TNFα, 
IFNγ, IL10 and IL17A cytokines can lead to elimination of the pathogen due to the 
adequate protective inflammatory immune response by TNFα, IFNγ and IL17A and 
the anti-inflammatory response by IL10 capable of containing the inflammatory 
damage to the host and a result in a disease score of 0. However, an inadequate IL10 
and IL17A response could lead to a stage of acute infection with a disease score of 1 
as IL17A has been found to be protective in the early stages of disease (Bai et al., 
2009; Scurlock et al., 2011; O’Meara et al., 2013a; O’Meara et al., 2013b). In the 
event of an unresolved infection, a cycle of chlamydial replication and subsequent 
inflammatory cytokine response of TNFα, IFNγ and dominated by IL17A in the near 
absence of IL10 may set in and the disease may subsequently progress towards stage 
2 and 3 leading to irreparable tissue damage in the host. 
 
Cytokines play an important role as immune markers of disease and treatment 
prognosis as they are involved in inflammation, immune response and repair 
(Meagre, 1991). In order to understand the role played by cytokines in chlamydial 
disease and to further establish markers of disease and protection, murine and guinea 
pig models have been used. An analysis of the role played by TNFα in chlamydial 
infection has provided disparate results. While the early studies in the mouse and 
guinea pig models linked TNFα to an early clearance of primary infection, challenge 
infection was associated with development of immunopathology (Darville at al., 
1995; Darville et al., 1997). These observations have been corroborated in recent 
studies which used gene knockout mice incapable of TNFα production, to study the 
role of TNFα in chlamydial pathology (Murthy et al., 201; Kamalakaran et al., 2013). 
Evidence of a role for TNFα in Chlamydia induced infertility in humans supports the 
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observations made in animal models (Srivastava et al., 2008; Ohman et al., 2009). 
Hence, it can be concluded that the relatively high levels of TNFα mRNA in koalas 
with current signs of chlamydial disease in this study could have potentially 
contributed to disease development. However, evidence to the contrary was reported 
in a recent study which observed reduced chlamydial shedding following challenge 
inoculation in vaccinated mice, which corresponded with T cells co-expressing IFNγ 
and TNFα than in those expressing IFNγ alone (Yu et al., 2011). This study indicates 
the need to interpret cytokine data in co-relation with other cytokines and not in 
isolation. Furthermore, the source of cytokine also needs to be determined in order to 
correctly analyse the data. 
 
IFNγ, which is the hallmark of a Th1 response, plays an important role in the host’s 
defence against chlamydial infection. It has been demonstrated through the use of 
IFNγ-/-, IFNγR-/- knockout mice that the absence  of IFNγ leads to an inability to 
resolve infection (Johansson et al., 1997; Rottenberg et al., 1999)  and wider 
dissemination of infection (Cotter et al., 1997; Perry et al., 1997). These studies in 
the mouse model of infection serve as an indicator of the definitive protective role 
played by IFNγ in chlamydial infection. However, an incomplete clearance of the 
organism in a natural host can lead to a chronic state of infection as well as 
associated tissue damage (Bobo et al., 1997). IFNγ is known to induce persistence in 
a dose dependent manner (Beatty et al., 1993) and could thereby cause bouts of 
recurrent infection leading to the chronic inflammation characteristic of chlamydiosis 
(Kunimoto and Brunham, 1985; Loomis and Starnbach, 2002). Therefore, in the 
absence of sterilising immunity during the primary infection, IFNγ may contribute to 
pathology rather than protection in a natural host. Thereby, the fact that we observed 
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elevated levels of IFNγ in the koalas with current signs of chlamydial infection is not 
surprising (Chapters 4 & 5). Similar findings of elevated IFNγ have been reported in 
cases of Chlamydia positive infertile women (Arno et al., 1990, Reddy et al., 2004; 
Srivastava et al, 2008).  
 
IL10 is a principal anti-inflammatory cytokine secreted by a broad range of immune 
cells such as Th1, Th2, Treg cells, subsets of Th17 cells, macrophages and other cells; 
(reviewed in Saraiva and Garra, 2010; Hakimi et al., 2014) . IL10 also suppresses the 
secretion of various pro-inflammatory cytokines involved in chlamydial pathogenesis 
(Igietseme et al., 2000). Further, an IL10 dominated response has been associated 
with susceptibility to chronic chlamydial infection in the mouse model (Wang et al., 
1999; Yang et al., 1999). Evidence for this is found in human IL10 gene 
polymorphism studies where the presence of IL10-1082GG genotype in the IL10 
gene was associated with higher levels of gene transcription (Ohman et al., 2006) and 
positively correlated with the prevalence of trachoma (Mozzato-Chamay et al., 2000) 
. Similarly, an up-regulation of IL10 has been linked to C. trachomatis related 
infertility (Agrawal et al., 2009; Gupta et al., 2009). However, the IL10-1082AA 
genotype which is associated with low transcription of IL10 gene (Turner et al., 
1997), has also been linked to increased risk of tubal damage in women in C. 
trachomatis related infertility (Ohman et al., 2009). While the role of IL10 gene 
polymorphism in chlamydial disease susceptibility is yet to be conclusively 
established, the importance of IL10 in chlamydial immunology cannot be discounted. 
Such contradictory observations were made in the current study also (Chapter 3 & 5). 
While koalas included in the cohort of current chlamydial disease (Chapter 3) 
expressed IL10 mRNA similar to the levels of IFNγ, koalas in the same classification 
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in Chapter 5 displayed lower IL10 gene expression levels. Though IL10 gene 
polymorphism studies were not a part of this study, as previous studies described 
above have associated both low and high levels of IL10 with chlamydial 
pathogenesis, it becomes important to analyse cytokine data not in isolation but in 
conjunction with other factors such as the stage of disease in individual hosts and 
presence of other confounding factors such as secondary infections. 
 
Our study is the first to analyse the role of IL17A cytokine in an infectious disease in 
any marsupial species. The role played by this cytokine in chlamydial infection has 
only recently begun to be studied. The IL17A cytokine is secreted by the Th17 cell 
lineage, and plays a role in the pathogenesis of chlamydial infection (Scurlock et al., 
2011; Andrew et al., 2013). Recent studies using animal models suggests that IL17A 
is involved in Chlamydia clearance in the early stages of disease and in the 
development of Th1 immunity (Bai et al., 2009; Andrew et al., 2013). An elevated 
IL17A response during chlamydial infection has also been associated with 
immunopathology during chlamydial infection in the mouse model (O’Meara et al., 
2013). Also, recent studies have reported strong expression of IL17A in women 
suffering from chlamydial cervicitis (Jha et al., 2011). The strong presence of IL17A 
mRNA in koalas with obvious signs of chlamydiosis (Chapter 5) and its absence in 
animals with chlamydial infection only is an indication of its contribution to the 
disease pathology.   Although the exact mechanism of IL17A pathogenesis is yet to 
be understood, it is known to be a potent neutrophil recruiter (Scurlock et al., 2011) 
and can also convert to Th1 cells thereby indirectly aiding in the clearance of this 
intracellular host.  
  
 183 
 
This project involved analyses of the cytokine profiles from koalas in the wild. 
Though some general trends were observed, variability in expression was seen in 
individual animals. This level of variability is not uncommon in an outbred 
population of a wild host. Apart from variables such as age, gender and stage of 
disease which would contribute to the observed variability, other factors such as an 
underlying Koala Retro Virus (KoRV) infection and MHC variability could also be 
responsible. Though, it was not within the scope of this project to analyse these 
variables, these factors are known to influence the immune response in hosts. 
 
Investigations regarding the influence of genetic diversity on the koala’s 
susceptibility to chlamydial infection are yet to be done. Nonetheless, inference can 
be drawn from independent studies. Microsatellite studies have shown that a low 
level of genetic diversity exists among certain island populations of koala such as the 
French island and the Kangaroo island populations (Houlden et al., 1996; Cristescu 
et al., 2009). However, these island populations have been reported to be free from 
chlamydial infection so far (Polkinghorne et al., 2013). Though low levels of genetic 
diversity have been linked to greater disease susceptibility (O’Brien and Evermann, 
1988), the absence of chlamydial disease in these populations could also be due to 
the absence of infection in the founder population and geographical isolation limiting 
the transmission of infection from the mainland koalas. Also, the fact that chlamydial 
infections of the koala are wide spread in the north-eastern mainland population of 
Australia which have been shown to be genetically diverse, indicates that this is not a 
key factor behind the high susceptibility of koalas to chlamydiosis (Houlden et al., 
1996). However, large scale studies utilising highly variable coding genes such as 
MHC class II molecules (Sommer, 2005) need to be undertaken to understand the 
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genetic diversity of Australian koala populations instead of the neutral markers such 
as the microsatellites allelic diversity and mitochondrial DNA variability (Houlden et 
al., 1996; Lee et al., 2010 ) . Lau et al. (2013) in a preliminary study, reported low 
MHCII diversity in two koala populations (South East Queensland and Port 
Macquarie) which were previously reported to have genetic diversity based on 
neutral markers (Houlden et al., 1996).  
 
Another confounding factor which could affect the immune response of the koala to 
chlamydial infection is the presence of KoRV infection. High prevalence of KoRV 
positive koalas in the northern Australia along with higher proviral copy numbers 
compared to southern koalas has been reported (Simmons et al., 2012). Looking at 
this study along with the higher prevalence of chlamydial infection in the northern 
koalas, it is tempting to assign an immunosuppressive role to KoRV. However, 
studies have failed to establish a link between the prevalence of KoRV RNA levels 
and chlamydiosis (Tarlinton et al., 2005). The data from our studies (Chapter 4, 5 & 
6) also does not suggest immunosuppression as all animals showed response to both 
the antigen as well as the mitogens used. However, cytokine response evaluation of 
southern koalas which have been reported to have lower levels of KoRV infection 
would help in a comparative evaluation. 
 
 Although the definitive role of IFNγ, TNFα, IL17A and IL10 responses in the koala 
in response to chlamydial infection needs to be established, our data supports the 
proposal that trends similar to animal and human studies were observed. A 
prophylactic vaccine which targets the development of a strong IFNγ and TNFα 
response that controls chlamydial infection in the initial stages, a moderate IL10 
 185 
 
response to contain the pro-inflammatory reactions of IFNγ and TNFα in the absence 
of a strong IL17A response can be perceived to be beneficial to the host in the light 
of current data. 
 
The qrtPCR assays developed as part of this study measure the mRNA levels of 
IFNγ, TNFα, IL17A and IL10 cytokine genes. However, it is known that many 
cytokines are regulated post transcription and the mRNA levels may not truly reflect 
the final biologically active protein molecule. The post transcriptional control of 
mRNA determines its stability and helps in the regulation of its expression as 
extended and over-production of pro-inflammatory and anti-inflammatory cytokines 
can exacerbate many disease conditions (Mino and Takeuchi, 2013). 
 
Post-transcriptional control of cytokines is principally achieved through trans-acting 
RNA binding proteins and cis-acting sequence elements, majorly in the 3’ 
untranslated region (3’UTR) consisting mainly of AU-rich elements (ARE) (Khabar, 
2014). These AREs act as binding site for certain RNA-binding proteins (RBP), 
which further determine mRNA stability and translation (Kafasla et al., 2014). Such 
mechanisms of post-transcriptional regulation have been reported for TNFα, IFNγ, 
IL17A and IL10. The post transcriptional control of TNFα is through cis-acting 
elements in the 3’ UTR region (Stamou and Kontoyiannis, 2010) which is recognised 
by RBPs such as tristetraprolin  (TTP), ARE/poly-(U) binding degradation factor 
1 (AUF1), T-cell-restricted intracellular antigen-1 (TIA1), and HuR (embryonic 
lethal abnormal vision system human homologue 1, ELAV1) (Mino and Takeuchi, 
2013). For IFNγ the ARE motifs in the 3’ region control mRNA stability and these 
motifs have been highly conserved through evolution (Khabar and Young, 2007). 
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These AREs are recognised by RBPs such as TTP, HuR and GAIT complex (the 
interferon-γ-activated inhibitor of translation complex) (Mino and Takeuchi, 
2013). Similar mechanisms have been demonstrated to exert post transcriptional 
control on IL10 (Powell et al., 2000) and IL17A (Chen et al., 2013) gene expression. 
 
Apart from post transcriptional control affecting the final expression of TNFα, the 
presence of pre-formed transmembrane TNFα which is expressed on the surface of 
activated macrophages and lymphocytes can also mediate biological activity 
(Horiuchi et al., 2010). Hence, there may be more functional TNFα present to exert 
the biological activity than is indicated by the mRNA levels. Taking into 
consideration the mechanisms which affect the final protein expression levels of the 
four mentioned cytokines, it would be prudent to accept that gene expression levels 
are a useful indicator of the final protein concentrations but far from perfect. 
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6.2 Major Outcomes and Significance of this Study 
1. This study cloned and characterised the previously unavailable koala cytokine 
sequences of TNFα, IL10 and IL17A. IFNγ, identified through a koala 
transcriptome study, was also analysed. The newly identified koala cytokine 
mRNA sequences have been deposited in GenBank. 
2. It is the first study to have looked at the cytokine response of the koala 
(Phascolarctos cinereus) to natural C. pecorum infection and disease. 
Significantly, it is the first such study amongst marsupials to have looked at 
the cytokine response pattern in a host-pathogen interaction; though cytokine 
sequences of certain other marsupial species such as brushtail possum and 
tammar wallaby have long been available.  
3. Proliferation was observed in the lymphocytes isolated from koala blood in 
response to mitogen (PMA/Ionomycin) and UV inactivated C. pecorum 
stimulation indicating the existence of a competent immune system in the 
koala in contrast to the previous labelling of this marsupial as an 
‘immunologically lazy’ animal (Wilkinson et al., 1992).  
4. Two cohorts of koalas were investigated for their cytokine responses as part 
of this study. In the first cohort of 10 animals, a significantly higher 
expression of TNFα, IL10 and IFNγ cytokine mRNA was observed  in koalas 
which suffered from current chlamydial disease as opposed to animals with 
evidence of chlamydial infection or no detectable infection. In the second 
cohort of 41 koalas, only a moderately high expression of TNFα, IL10 and 
IFNγ cytokine mRNA was reported in animals with current chlamydial 
disease as opposed to only infection.  However, there was a markedly high 
IL17A mRNA expression in animals which suffered from current urogenital 
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tract chlamydial disease in this cohort. Hence, the presence of IL17A mRNA 
can be considered as an immune marker for chlamydial disease severity and 
pathogenesis.  
 
6.3 Future Directions 
This study provides the first look at cell mediated immune response of the koala to 
C. pecorum infection using species specific assays and sets the foundation for further 
investigations in this field. Differences could be observed in the systemic cytokine 
response of the koala with and without current signs of C. pecorum disease. 
However, high levels of variation were observed in individual animals. The reasons 
for such levels of variation can be manifold. Future studies should aim to minimise 
these variations by the use of age and sex matched controls. Further, the stage of 
disease may also affect the cytokine response pattern. Though it would be ethically 
unacceptable to not treat an animal diagnosed with chlamydiosis, koalas can be 
grouped into different stages of disease based on their chlamydial disease status as 
described by Wan et al. (2011). The tools described as part of this study can be used 
to provide a better understanding of the cytokine expression pattern at different 
stages of the disease and could help to better elucidate between protective and 
immunopathogenic responses.  
 
This study has looked at the systemic cytokine response pattern of koalas with and 
without chlamydial disease. However, cytokines mainly have a localised mode of 
action during an infection process. Moreover, the pathology caused by C. pecorum is 
also localised. Hence, looking at the cytokine profile in discharges at the urogenital 
and ocular site in confirmed cases of chlamydiosis can provide a true picture of the 
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disease pathogenesis. The current study utilised the cytokine qrtPCR assays to 
understand the chlamydial disease pathogenesis in the koala. Even though these 
assays do not serve as diagnostic tools for chlamydial infection, they can be used to 
determine the necessity of treatment interventions such as antibiotic treatments, 
which are deemed harmful for the koala (Griffith et al., 2010). Moreover, the 
principal aim of these assays would be to determine the mechanisms of chlamydial 
disease pathogenesis and to understand what cytokine profile confers protection from 
the development of chlamydial disease pathology. This information can then be used 
either to target or circumvent such cytokine profile development in vaccine trials.  
 
There is a shortage or near-absence of cross reacting mammalian immune reagents 
which can be used to study the marsupial immune response. This has limited the 
progress in the understanding of marsupial immunology. The qrtPCR assays 
described as part of this project have added to the very limited tools available to 
evaluate the marsupial immune system. Even though these assays are specifically 
designed for the koala, the level of cytokine sequence conservation (80-90%) that has 
been observed between different marsupial species provides possibilities for its use 
in other marsupial species. These assays could be very useful in marsupial species 
that are closely related to the koala and belong to the same sub order such as the 
wombats (Cardillo et al., 2004). Even though it is ideal to develop species specific 
assays, it is important to test the cross reactivity of these assays in other marsupial 
species as there is considerable shortage of sequence information and use of already 
established assays will help minimise the loss of time and resources in understanding 
the immune response of many of these vulnerable marsupial species.  Though this 
study has provided baseline data for future investigations in the field of koala 
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Chlamydia immunopathogenesis, much work remains to be done. It has highlighted 
the possible similarities in disease progression between the C. trachomatis infection 
in humans and C. pecorum infection in the koala. However, the challenges of 
working with this wild life host have also been recognised. Additional longitudinal 
studies are necessary to gain a complete understanding of chlamydial pathogenesis in 
the koala for the benefit of individual animals as well as for the long-term survival of 
this species.  
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assay 
 
Example of Standard Curve Analysis for IL10 qrtPCR assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 203 
 
Example of Melt Curve Analysis for IL10 qrtPCR assay 
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Supplementary material 2: Standard curve and melt curve analyses of TNFα qrtPCR 
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Example of Standard Curve Analysis for TNFα qrtPCR assay 
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Example of Melt Curve Analysis for TNFα qrtPCR assay 
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Supplementary material 3: Standard curve and melt curve analyses of IFNγ qrtPCR 
assay 
 
Example of Standard Curve Analysis for IFNγ qrtPCR assay 
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Example of Melt Curve Analysis for IFNγ qrtPCR assay 
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Supplementary material 4: Standard curve and melt curve analyses of IL17A qrtPCR 
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Example of Standard Curve Analysis for IL17A qrtPCR assay 
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Example of Melt Curve Analysis for IL17A qrtPCR assay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
